Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2023 Aug 29;21(8):e3002250. doi: 10.1371/journal.pbio.3002250

Senescence in yeast is associated with amplified linear fragments of chromosome XII rather than ribosomal DNA circle accumulation

Andre Zylstra 1,¤a, Hanane Hadj-Moussa 1,#, Dorottya Horkai 1,¤b,#, Alex J Whale 1, Baptiste Piguet 1, Jonathan Houseley 1,*
Editor: Sarah E Zanders2
PMCID: PMC10464983  PMID: 37643194

Abstract

The massive accumulation of extrachromosomal ribosomal DNA circles (ERCs) in yeast mother cells has been long cited as the primary driver of replicative ageing. ERCs arise through ribosomal DNA (rDNA) recombination, and a wealth of genetic data connects rDNA instability events giving rise to ERCs with shortened life span and other ageing pathologies. However, we understand little about the molecular effects of ERC accumulation. Here, we studied ageing in the presence and absence of ERCs, and unexpectedly found no evidence of gene expression differences that might indicate stress responses or metabolic feedback caused by ERCs. Neither did we observe any global change in the widespread disruption of gene expression that accompanies yeast ageing, altogether suggesting that ERCs are largely inert. Much of the differential gene expression that accompanies ageing in yeast was actually associated with markers of the senescence entry point (SEP), showing that senescence, rather than age, underlies these changes. Cells passed the SEP irrespective of ERCs, but we found the SEP to be associated with copy number amplification of a region of chromosome XII between the rDNA and the telomere (ChrXIIr) forming linear fragments up to approximately 1.8 Mb size, which arise in aged cells due to rDNA instability but through a different mechanism to ERCs. Therefore, although rDNA copy number increases dramatically with age due to ERC accumulation, our findings implicate ChrXIIr, rather than ERCs, as the primary driver of senescence during budding yeast ageing.


What causes pathology in aging yeast cells? Circular DNAs called ERCs are implicated in yeast aging but their mode of action is largely unknown. This study detects no impact of ERCs on gene expression or senescence during yeast aging, but identifies a tight link between ageing and a large chromosome XII fragment that likely forms through ribosomal DNA replication errors.

Introduction

Replicative ageing in the budding yeast Saccharomyces cerevisiae is a widely used model of ageing in dividing cells [13]. Under this paradigm, age is the number of budding events undergone by a mother cell, and life span is the total number of divisions prior to a permanent loss of replicative capacity [4]. Long-term imaging shows that cell cycle duration remains constant for most of the replicative lifetime but lengthens dramatically in the last few divisions [57]. This indicates a period of pathological ageing that precedes loss of replicative viability, although the cause of this transition to a pathological ageing state is still debated.

Ageing cells display a spectrum of molecular phenotypes including dramatic changes in gene expression. This has been attributed to a loss of transcriptional repression due to histone depletion [8,9], the induction of a widespread but defined environmental stress response (ESR) [1013] and the uncoupling of translation from mRNA abundance [14]. Whatever the cause, ageing yeast undergo widespread induction of coding and noncoding loci that are normally repressed for RNA polymerase II transcription during vegetative growth and increase expression of stress and environmental response factors while the abundance of mRNAs encoding translation and ribosome biogenesis components is decreased [8,11,12,15,16]. Similarly, and perhaps consequently, the proteome becomes dysregulated, aggregation prone, and increasingly uncoupled from the transcriptome; gene expression becomes unresponsive; and the metabolome shifts towards reduced growth and substrate uptake [14,1719]. Interestingly, single-cell techniques have revealed that the onset of senescence is a discrete process initiated abruptly at the senescence entry point (SEP) [5,20]. After the SEP, cells exhibit an extended G1 phase marked by intense foci of the tagged mitochondrial membrane protein Tom70-GFP and low levels of cyclin Cln1. However, cell growth does not pause, leading to rapid cell size expansion and pathological cytoplasmic dilution coincident with nuclear and nucleolar growth [5,6,17,20,21]. One or more of these phenotypes may cause the permanent loss of replicative potential that defines yeast replicative life span, and the reproducible time from the SEP to loss of replicative viability suggests that senescence limits life span to some extent [5], but we and others have observed ageing trajectories resulting in loss of replicative potential without apparent senescence [22,23], so other non-SEP mechanisms must also limit life span and the causal connection between the SEP and loss of viability remains unproven.

The most prominent theory of yeast ageing focuses on accumulation of ERCs, which arise during homologous recombination within the highly repetitive ribosomal DNA (rDNA) locus [2426]. ERCs are replicated in each cell cycle and are asymmetrically retained in mother cells at mitosis by the SAGA and TREX-2 complexes, such that ERC copy number rises exponentially during ageing to the point that effective genome size increases 30% to 40% in 24 hours [15,20,24,27,28]. Due to this behaviour, ERCs are very plausible “ageing factors” that arise early in ageing and later cause nucleolar fragmentation [24,29,30]. Important components of this theory are Sir2, the eponymous member of the highly conserved sirtuin protein deacetylase family, and Fob1, which localises to the rDNA replication fork barrier (RFB) site. Fob1 stalls replication forks at the RFB and averts head-on collision with RNA polymerase I, but resolution of the stalled forks can be recombinogenic through repair events leading to ERC formation [26,31,32]. In support of the ERC theory, SIR2 deletion destabilises the rDNA, promotes ERC accumulation and rDNA copy number variation, and shortens yeast life span, whereas FOB1 deletion or SIR2 overexpression extend life span [26,33]. ERC-encoded noncoding RNAs are abundantly expressed by RNA polymerase II with a concomitant accumulation of activating epigenetic marks such as H3K4me3, while the additional ribosomal DNA genes are transcribed by RNA polymerase I [15,16,20]. As such, it is not hard to imagine that titration of nuclear and nucleolar factors by thousands of ERCs could imbalance the protein coding transcriptome and/or ribosome synthesis.

Anti-ageing interventions with cross-species efficacy, such as caloric restriction and mTOR inhibition, also reduce rDNA instability and recombination through Sir2 [3437]. Remarkably, there are indications that rDNA instability and copy number variation might be relevant to animal ageing and pathology as rDNA copy number variation has been reported during Drosophila and mouse ageing [38,39], in human neurodegenerative disorders [40], and in cancer [4144]. Circular DNAs containing rDNA sequence have also been observed in Drosophila and human cells [45,46]. However, although accumulation of ERCs in ageing yeast was first reported a quarter of a century ago, there remains a conspicuous lack of analogous data for any other model organism [24]. Nonetheless, recent publications showing a tight connection between ERC accumulation and ageing phenotypes in yeast strongly suggest that ERCs are the proximal cause of age-related cell cycle disruption and senescence. Neurohr and colleagues observed that post-SEP mother cells are rejuvenated through rare events in which the entire ERC complement is transmitted to a daughter cell; Ünal and colleagues observed that ERCs are compartmentalised and degraded during meiosis in aged cells [47,48]; while Morlot and colleagues reported that cell cycle disruption and the SEP coincide with exponential ERC accumulation and concomitant excess rDNA transcription [19,20]. Furthermore, Meinema and colleagues recently reported that extended association of ERCs with nuclear pore complexes can promote the progressive decay of nuclear pores that occurs during ageing in yeast [49,50].

These studies strongly suggest that ERC accumulation is pathological, but there is little mechanistic evidence of how ERC-dependent pathology may be mediated. To study this, we used mutants in ERC formation and retention to define the effect of ERCs on mRNA abundance and the SEP but unexpectedly found no connection with ERCs. Instead, we show a strong correlation between amplification of a large linear fragment of chromosome XII (ChrXIIr) and the SEP, suggesting that this may be the unanticipated cause of senescence in yeast.

Results

To investigate the role of ERC accumulation during replicative ageing in S. cerevisiae, we examined aged mutant cells that fail to accumulate ERCs during ageing. Homologous recombination-deficient rad52Δ cells cannot form ERCs, whereas spt3Δ and sac3Δ cells lack components of SAGA and TREX-2 so cannot retain ERCs in mother cells (Fig 1A) [25,28]. By studying mutants in different pathways required for age-linked ERC accumulation, we aimed to separate effects caused by ERCs from unrelated effects of individual mutations.

Fig 1. ERCs do not cause genome-wide gene expression dysregulation.

Fig 1

(A) Schematic of ERC accumulation during replicative ageing, indicating the processes that are impaired in rad52Δ, spt3Δ, and sac3Δ mutants. (B) Schematic of the MEP culture system used to isolate aged populations for analysis. Times of biotin labelling and harvest are shown. (C) PCA summary for young and aged poly(A)+ RNA-seq libraries of wild-type and indicated ERC mutants aged in YPD using the MEP. Arrows show progression across time in culture; background colour graduations indicate sample time point. Major GO categories for each PC are indicated based on the 300 highest rotation genes underlying the PC in either direction, full GO term enrichment analysis in S7 File. (D) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from wild-type and indicated mutants. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. Data for each genotype and age calculated as the log2 mean normalised read counts per gene of 3 biological replicates for wild-type, spt3Δ, and sac3Δ or 2 biological replicates for rad52Δ. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; GO, gene ontology; MEP, mother enrichment programme; PC, principal component; PCA, principal component analysis.

For purification of aged cells, we employed the mother enrichment program (MEP) devised by Lindstrom and Gottschling [51]. MEP cells proliferate normally until β-estradiol is added to a culture, after which all newborn daughter cells are rendered inviable. This allows mother cells to reach advanced replicative age in batch culture without proliferation of young cells depleting media components. Mother cell walls are labelled with reactive biotin when young, which allows recovery of the same cells on magnetic streptavidin beads at aged time points after fixation (Fig 1B). Unlike most ageing systems in yeast, the MEP uses diploid cells, which are more resilient both to random mutations that could circumvent the MEP and to toxic double-strand breaks that occur increasingly with age and result (in diploids) in loss of heterozygosity [51,52].

Not all mutations that alter ERC abundance in young cells have equivalent effects in aged cells. For example, young fob1Δ mutant cells contain fewer ERCs, but ERC abundance in aged diploid fob1Δ MEP cells hardly differs from wild type (S1A Fig) [52]. We therefore confirmed ERC abundance in all 3 mutants by Southern blot. Reassuringly, deletion of RAD52 in the MEP background abrogated ERC accumulation (30× reduction) [25,26], while deletion of SPT3 or SAC3 dramatically reduced ERC accumulation during ageing relative to wild type (10× and 5× reduction, respectively) (S1B Fig) [28].

Together, rad52Δ, spt3Δ, and sac3Δ form a set of 3 mutants that accumulate very few ERCs during ageing compared to wild type. Consistent differences that emerge during ageing between each mutant and the wild-type form candidate effects that could be attributable to ERCs, whereas differences observed in only a single mutant or that are already present in young cells prior to ERC accumulation must be attributed to genotype effects rather than ERCs. We note that rad52Δ and sac3Δ are short lived, whereas the life span of spt3Δ is almost identical to wild type, providing a spectrum of lifespans to allow separation of terminal phenotypes from effects of ERCs [25,53,54].

Age-linked transcriptomic dysregulation is independent of ERCs

The RNA polymerase II transcriptome should provide a sensitive readout of the impact of ERCs on the ageing process, reporting both changes in overall distribution of mRNA abundance and also the expression of individual genes. Individual gene expression differences were predicted to be particularly informative, indicating stress response pathways and/or metabolic feedback circuits activated due to pathological impacts of ERC accumulation.

Poly(A)+ RNA-seq libraries were derived from MEP wild-type, spt3Δ, and sac3Δ cells in triplicate and rad52Δ cells in duplicate. Cells were harvested at log phase and after 24 and 48 hours of ageing, times at which approximately 100% and approximately 30% to 40% of wild-type cells remain viable, respectively (Fig 1B) [15,51]. Expression of 1,186 genes enriched for carbohydrate metabolism, respiration, and cell wall organisation increased significantly at 48 hours compared to log phase in wild type, while 870 genes enriched for ribosome synthesis and translation decreased significantly, all of which is highly consistent with previous ageing gene expression studies and supports the reliability of our dataset (DESeq2, Benjamini–Hochberg (BH) corrected false discovery rate (FDR) < 0.05, log2-fold change threshold ± 0.5) (S1C Fig) [8,12,15].

Our strategy of defining the effects of ERCs during ageing based on similar gene expression changes in otherwise disparate mutants that all lack ERCs (spt3Δ, sac3Δ, and rad52Δ) relies on these mutations having different effects on gene expression in young cells. In support of this, principal component analysis (PCA) performed on the log phase samples shows no association between any pair of mutants (S1D Fig). In more detail, pairwise differential expression analysis at log phase uncovered >1,000 significantly differentially expressed genes in each mutant compared to the wild type (DESeq2, BH-corrected FDR < 0.01, log2-fold change threshold ± 0.5), and of the 2,606 genes that are significantly differentially expressed in at least 1 mutant, only 197 (7.5%) change in the same direction in all 3 mutants (93 up, 104 down). Hierarchical clustering of the 2,606 genes also shows little overlap between the effects of the different mutants (S1E Fig). Notably, spt3Δ and sac3Δ, which might be expected to have similar transcriptomic effects given that Spt3 and Sac3 are physically associated and link promoters to the nuclear pore, actually have almost diametrically opposite effects on gene expression.

We then performed PCA on the full RNA-seq dataset and found that samples segregated by time on PC1 (47% of variance) and by genotype on PC2 (12% of variation). PC1 score increased with age in all genotypes, and the progression was strikingly similar between wild type and spt3Δ (Fig 1C, compare grey and purple). The 24- and 48-hour transcriptomes of rad52Δ cells clustered together, consistent with these very short-lived cells having reached the end of their replicative life span by 24 hours [25], though the yield of cells did not decrease from 24 to 48 hours and the increased chronological age of the nondividing rad52Δ cells evidently did not impact the transcriptome (Fig 1C, green). In contrast, the sac3Δ transcriptome progressed on PC1 both from log to 24 and from 24 to 48 hours, but less so than wild type, consistent with slower but ongoing division (Fig 1C, orange).

Yeast cells are reported to undergo genome-wide transcriptional derepression during ageing, particularly of low-expressed genes [8]. This is clearly visible in MA plots, which display the change in expression with age of each gene as a function of the average expression of that gene (Fig 1D). In wild type, genes with low average expression are strongly induced with age, genes with intermediate expression change little relative to average, and abundant mRNAs decrease relative to average, imparting a characteristic skew away from horizontal to the distribution (Fig 1D, dotted line). The MA plot for spt3Δ is essentially identical to wild type (Fig 1D, compare grey and purple), and a similar effect is observed in rad52Δ and sac3Δ (Fig 1D, compare grey to green and orange).

We therefore conclude that the dramatic remodelling of mRNA abundance which accompanies yeast replicative ageing is completely independent of the massive genomic and epigenomic changes resulting from ERC accumulation.

ERC accumulation exerts minimal effects on individual genes

Bulk transcriptome properties could mask differences in the behaviour of large numbers of genes. However, for the set of genes significantly differentially expressed between log phase and 48 hours in wild type (S1C Fig), the direction and magnitude of mRNA abundance change during ageing correlates strongly between wild type and mutants (Fig 2A). This is highly consistent with other studies showing common age-related transcriptional patterns between wild type and various mutant genotypes [12,15]. This analysis further shows that broad age-related gene expression changes occur regardless of ERC accumulation.

Fig 2. Expression change of individual genes is not associated with ERC accumulation.

Fig 2

(A) Plots of change in log2 mRNA abundance between log phase and 48-hour-aged cells for each individual mutant compared to wild type. Only the 1,186 genes called as significantly differentially expressed with age in wild type (DESeq2 pairwise comparison of wild-type 48-hour-aged vs. log phase, BH-corrected FDR < 0.05, log2-fold change threshold ±0.5) are included. Slopes calculated by linear regression. Data for each genotype and age calculated as the log2 mean normalised read counts per gene of 3 biological replicates for wild type, spt3Δ, and sac3Δ or 2 biological replicates for rad52Δ. Log2 change calculated as the difference between log2 means for 48 hour and log phase samples within a genotype. (B) Hierarchical clustering of log2 normalised mRNA abundance for the 158 genes significantly differentially up-regulated in the presence of ERCs based on Linear Model 1 (DESeq2 linear model factor “high” vs. “low” ERC abundance BH corrected (FDR) < 0.05, log2-fold change threshold ±0.5). The colour scale indicates the log2 fold change relative to the per-gene median. Individual biological replicates shown (6 for wild type; 3 for spt3Δ and sac3Δ; 2 for rad52Δ). Wild-type cells with TRP1 gene repaired are included in addition to standard MEP wild type and are almost identical. Full output of the model is provided in S1 File. (C) Violin plot for the difference in log2 mean normalised mRNA abundance between wild type and given mutants at log phase and after 48 hours of ageing for the cluster 2 genes shown in (B). Solid horizontal lines within violins indicate median values, while lower and upper quartiles are indicated by dotted horizontal lines. (D) Hierarchical clustering of log2 normalised mRNA abundances for the set of 40 Sir2-regulated genes defined by Ellahi and colleagues [62]. Individual biological replicates shown (3 for wild type, spt3Δ, and sac3Δ and 2 for rad52Δ). Clustering procedure and scale as in (B). The numerical data underlying this Figure can be found in S8 File. BH, Benjamini–Hochberg; ERC, extrachromosomal ribosomal DNA circle; FDR, false discovery rate; MEP, mother enrichment program.

We next looked for changes in more specific processes or pathways that might be ERC dependent. We performed standard pairwise differential expression analyses between wild type and each mutant in 48-hour-aged samples and looked for genes consistently over- or underexpressed in all mutants lacking ERCs (DESeq2, BH-corrected FDR < 0.05, log2-fold change threshold ± 0.5). However, this very conservative approach only identified 10 genes, and, worryingly, one of these was TRP1, the marker used for deleting SPT3, SAC3, and RAD52. We therefore turned to a more powerful linear modelling approach, and to control for TRP1 auxotrophy added 3 replicate ageing time-courses for a MEP wild-type strain with the TRP1 locus repaired.

A linear modelling approach to differential expression analysis [55] considers many datasets together and attempts to explain the differences in expression of each gene between the datasets based on multiple independent variables. For example, in a dataset where age and genotype vary between samples, linear modelling would estimate separate contributions (model coefficients) of age and genotype to the change in expression of each gene; some genes may be more affected by age and have a higher age coefficient, others by genotype and have a higher genotype coefficient. The significance of the contribution of each variable to the differential expression of each gene is also calculated, allowing the set of genes significantly affected by each experimental variable to be extracted. This means that linear modelling can identify genes particularly influenced by one (or more) variable(s) in complex experiments that go beyond simple pairwise comparisons.

We used 4 categorical independent variables in our model: Genotype (wild type, spt3Δ, rad52Δ, sac3Δ), TRP1 (present, not present), Age (log phase, 24 hours, 48 hours), ERC abundance (high, low). Aged wild-type samples were classified as “high” ERC abundance, and all other samples were classified as “low” since aged spt3Δ, rad52Δ, and sac3Δ cells show little accumulation of ERCs above log phase (S1B Fig). Of 161 genes significantly differentially expressed between “high” and “low” ERC abundance (DESeq2, BH-corrected FDR < 0.05, log2-fold change threshold ± 0.5), only 3 genes (CSS1, PHO11, and PHO12) were significantly down-regulated, while 158 genes were significantly up-regulated in high ERC abundance samples and therefore classified as “ERC-induced.” Six genes were differentially expressed depending on TRP1, but these did not overlap with genes affected by ERC abundance (Linear Model 1, S1 File).

Following hierarchical clustering, we split the 158 candidate ERC-induced genes into 2 large clusters, which most noticeably differ in the rad52Δ dataset (Fig 2B). Cluster 1 genes were mostly highly expressed in rad52Δ and low in spt3Δ and sac3Δ (Fig 2B, top). This cluster includes annotations covering the regions of chromosomal rDNA and ERCs that are normally silenced by Sir2 [5659]. Age-related induction of RNA polymerase II–transcribed noncoding RNAs within rDNA repeats was very low in all 3 low-ERC mutants but increased dramatically with age in wild type, coherent with high transcriptional activity of these regions on ERCs (Figs 2B and S2A) [16]. In fact, the IGS1-F noncoding RNA expressed from the E-pro promoter becomes the most abundant poly(A)+ RNA in aged wild-type cells (S2B Fig). Discovery of these transcripts validates the linear model approach, which essentially identifies genes as differentially expressed based on ERC abundance if they change less with age in the mutants than in the wild type. Remaining cluster 1 genes are dominated by retrotransposable elements (23/46 genes), expression of which is known to increase in rad52Δ and decrease in spt3Δ [60,61]. These follow the expected genotype-specific behaviour starting at log phase, which makes it unlikely that retrotransposable elements are bona fide ERC-induced transcripts.

In contrast, cluster 2 is largely composed of single-copy protein coding genes, functionally enriched for negative regulation of ATPase activity, negative regulation of hydrolase activity, and cell wall organisation. However, the following lines of reasoning lead us to conclude that these genes and ontologies are not related to ERC accumulation. Firstly, the difference in expression of these genes between wild type and the mutants is highest at log phase and decreases with age (Fig 2C); this means that the expression differences are most substantial prior to ERC accumulation and therefore must be attributed to overlapping effects of the mutant genotypes rather than ERC accumulation. Indeed, 27% [30] of these genes were among the 93 mRNAs identified above as significantly more abundant in all 3 mutants at log phase. Secondly, the median model coefficient for the effect of ERC abundance on cluster 2 genes is similar to the model coefficients for Age and Genotype (S2C Fig), indicating that ERCs are, at most, a mid-ranking contributor to the differential expression of these genes.

Heterochromatic regions silenced by Sir2 followed the behaviour of ERC-regulated transcripts (rDNA and mating type loci are in cluster 1), so we asked whether titration of Sir2 by ERCs can explain the reported age-linked induction of Sir2-regulated protein coding genes [33]. Of the 40 genes repressed by the SIR complex [62], of which Sir2 is the active deacetylase, most are induced with age irrespective of ERCs as induction is similar to wild type in rad52Δ or sac3Δ (Fig 2D). The model coefficients for “high” ERC abundance and 48-hour Age for these genes, interpretable as the log2 expression change attributable to ERC accumulation and to age, were 0.7 ± 1.3 and 1.8 ± 1.7, respectively (median ± interquartile range) (S2D Fig). By comparison, these values for the cluster 2 genes were 1.7 ± 1.4 (for “high” ERC abundance) and 1.5 ± 1.5 (for 48-hour Age). Therefore, our data show that ERC accumulation may contribute to the derepression of some Sir2-regulated genes, but to a lesser extent than the derepression of the same genes that occurs due to increasing age.

Overall, despite the vast accumulation of ERCs during ageing and the resultant massive production of polyadenylated noncoding RNA, we could not identify protein coding genes for which the change in mRNA abundance during ageing is primarily driven by ERC accumulation.

ERC accumulation is not the only pathway to the SEP

ERC accumulation immediately precedes the SEP, which is marked by formation of very bright foci of the mitochondrial outer membrane protein Tom70-GFP in G1 [5,20]. Yeast cells also undergo volume growth after entering the SEP to a point that cytoplasmic dilution could induce dysfunction [21], but it is unclear whether ERCs contribute to this growth. Both cell size and Tom70 intensity can be quantified by imaging, so we set up a high-throughput assay using the Amnis ImageStream flow cytometry system to image hundreds of individual MEP cells from purified aged MEP populations [22].

Fluorescence images of Tom70-GFP were captured to assess onset of the SEP, with ribosome component Rpl13a-mCherry as a control that does not accumulate substantially or form foci during ageing in wild type [7]. Brightfield and wheat germ agglutinin (WGA)-stained images were also acquired for each cell; cell area is calculated from brightfield, while WGA intensity forms a quantitative marker of replicative age that correlates with manual bud scar counts in wild type and spt3Δ, with a slight underestimate in rad52Δ (see comparison with manual bud scar counts in S3A Fig) [14,63,64]. As expected, in wild-type cells, Tom70-GFP and WGA intensity increased markedly from log phase to 24 hours and from 24 to 48 hours (Fig 3A and 3B). Cell size increased particularly during the first 24 hours of ageing (Fig 3C), while Rpl13a-mCherry increased only slightly (<1.5-fold, S3B Fig).

Fig 3. Mutants lacking ERCs still display signatures of the SEP.

Fig 3

(A) Imaging flow cytometry analysis of Tom70-GFP intensity, which increases hugely in G1 cells after the SEP [5]. Cells were gated for streptavidin staining (aged samples only), which filters out young cells, then for circularity, which selects towards G1 cells and removes clumps. The left graph shows individual cells in a representative population with a bar at the median. The right graph compares medians of biological replicates. p-Values calculated from 2-way ANOVA with post hoc Tukey test using genotype and age as independent variables, n = 4. Red p-values indicate significance at p < 0.05. (B) Analysis of WGA staining to show relative age. Samples and analysis as in (A). (C) Analysis of cell size in pixels extracted from brightfield images. Samples and analysis as in (A). (D) Representative brightfield images of cells from log phase cultures of indicated genotypes. Samples were fixed in ethanol and sonicated to disperse cell clumps. Quantification shows the fraction of cell particles containing 3 or more cells (a particle being a unit of 1 or more cells that is not dispersed by sonication), analysis by 1-way ANOVA with post hoc Tukey test, n = 3. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; SEP, senescence entry point; WGA, wheat germ agglutinin.

In spt3Δ, Tom70-GFP intensity increased with age to be significantly, although not substantially, lower than wild type at 24 hours but did not increase from 24 to 48 hours despite cells reaching equivalent age to wild type (Fig 3A and 3B). spt3Δ cells were slightly smaller at all ages but still grew substantially with age, while Rpl13a-mCherry intensity decreased with age, though again the change was small (Figs 3B and S3C). Cells lacking Sac3 aged more slowly than wild type, reaching an average age in 48 hours only slightly higher than wild-type cells in 24 hours, but taking this into account behaved in a very similar manner to the spt3Δ mutant (S3C Fig). In contrast, rad52Δ cells showed significantly higher Tom70-GFP fluorescence than wild type at 24 hours, even though rad52Δ cells were younger, as well as being slightly, though not significantly, larger (Fig 3A and 3B). None of these parameters changed from 24 to 48 hours consistent with rad52Δ cells reaching the end of replicative life before 24 hours, such that by 48 hours, wild-type cells had caught up in Tom70-GFP and cell size. Taken together, we observe essentially no correlation between SEP onset or cell size and the presence or absence of ERCs across this set of mutants, with rad52Δ being a particular outlier.

This implies that aged cells lacking ERCs should still become senescent, defined by a profound increase in cell cycle time. This is hard to assay for rad52Δ and sac3Δ mutants due to early loss of viability and slow growth but is testable in spt3Δ cells, which follow similar ageing kinetics to wild type (S3A Fig). Young cells placed on YPD agar by micromanipulation rapidly divide and form colonies, but post-SEP cells cycle extremely slowly, which should delay the generation of a daughter cell capable of forming a colony. We measured the sizes of colonies produced in 24 hours from individual young and 48-hour-aged cells, including only viable cells that gave rise to a colony within 72 hours, and observed an equivalent massive reduction in colony size for both aged wild-type and aged spt3Δ cells compared to young cells (S3D Fig). This shows that despite accumulating 10-fold less ERCs, spt3Δ cells become senescent with age as evidenced by very slow cell division, consistent with the Tom70-GFP intensity data. In contrast, wild-type cells aged on galactose accumulate high levels of ERCs but show no delay in colony formation consistent with their very low Tom70-GFP signal [22], further separating ERC accumulation from senescence.

To confirm that ageing phenotypes are not connected with ERC accumulation, we examined other previously described markers. Firstly, the size of the nucleolus, visualised as the area occupied by the RNA polymerase I marker Rpa190-GFP, has been shown to expand as cells age [20]. This is thought to result from increased rDNA copies arising through ERC amplification occupying more space and recruiting more ribosome biogenesis factors; however, we observe that this increase of nucleolar size with age occurs in wild type and in both rad52Δ and spt3Δ mutants that accumulate ≥10-fold less ERCs (S3E Fig). Secondly, the vacuole expands with age and increases in pH, resulting in a higher signal from a Vph1-mCherry reporter [65]. Again, we observe the same phenotype in wild-type and mutant cells, except that the increase stops at 24 hours in the rad52Δ mutant as these cells have already completed their replicative life span (S3F Fig). Our imaging data for Tom70-GFP, Vph1-mCherry, and Rpa190-GFP, as well as direct measurements of growth rate and gene expression dysregulation all lead to the same conclusion: that age-associated changes and the onset of senescence marked by the SEP occur independent of ERCs.

We expanded on these surprising observations using epistasis assays, in which rad52Δ was combined with spt3Δ or sac3Δ. We expected that the high Tom70-GFP and low WGA phenotypes of the rad52Δ mutant would be dominant in these double mutants, as it seemed likely that whatever persistent DNA damage drives the SEP in rad52Δ cells should occur irrespective of SAGA or TREX-2 disruption. However, we actually observed a strong additive effect. One terminal phenotype of replicatively aged yeast, particularly in diploid MEP cells, is a cell division defect that causes <5% of cells to form large multicellular aggregates (S3G Fig). However, in the rad52Δ spt3Δ and rad52Δ sac3Δ double mutants, every mother cell formed such an aggregate within 24 hours, making purification impossible. This phenotype was prominent even in log phase populations (Fig 3D), and quantifying individual particles (a particle being 1 or more cells not separable by sonication) showed that the majority of double mutant cell particles were clusters of 3 or more cells, often containing 10+ cells (Fig 3D). This observation suggests that although rad52Δ mutants lack ERCs, rad52Δ mother cells may contain another toxic species that is normally retained in mother cells by SAGA/TREX-2.

Overall, phenotypic analysis of spt3Δ and sac3Δ mutants shows that ERC accumulation makes only a minor contribution to the SEP and that rad52Δ develops a very strong SEP phenotype at a young age despite a complete absence of ERCs. Therefore, the presence or absence of ERCs does not define the SEP. Furthermore, the unexpected outcome of the epistasis assay raises the hypothesis that another DNA species is present in rad52Δ mutant cells, one that is normally retained in mother cells by SAGA and TREX-2 (just like ERCs) and which causes a cytokinesis defect if communicated to daughter cells.

A transcriptional signature of the SEP

The uncoupling of SEP markers from ERC accumulation prompted us to reanalyse our gene expression data looking for changes associated with the SEP instead of ERCs. To do this, we used the same dataset and linear modelling approach applied for ERCs in Fig 2, but with altered parameters to test the contribution of the SEP instead of ERCs to differential expression. We rebuilt the linear model with categorical independent variables for Age, Genotype, and TRP1 as before, but substituted the ERC abundance variable for a continuous variable representing SEP status based on Tom70-GFP (Tom70-GFP intensity median values from Figs 3A and S3C scaled linearly from 0 to 1) (Linear Model 2, S2 File).

This model discovered 187 genes significantly differentially expressed based on the SEP variable (DESeq2, BH-corrected FDR < 0.05, log2-fold change threshold ± 0.5) (Fig 4A). Importantly, the model coefficient for SEP was far higher than other model coefficients for these genes, showing that the SEP largely explains gene expression changes for these genes across the experiment with little contribution from Age or Genotype (Fig 4B). This should be contrasted with the weak effect of ERC abundance on potential ERC-induced genes (S2C Fig). GO term enrichment analysis of the gene set differentially expressed based on the SEP revealed enrichments for sporulation, specifically genes for prospore formation, spore wall assembly and septins, as well as iron transport.

Fig 4. A gene expression signature for the SEP.

Fig 4

(A) Hierarchical clustering of log2 mRNA abundance for 187 genes called by a DESeq2 Linear Model 2 as significantly different between datasets based on the SEP (Tom70-GFP medians from Figs 3A and S3C) (DESeq2 continuous linear model factor: median Tom70-GFP scaled to between [0,1], BH-corrected FDR < 0.05, log2-fold change threshold ±0.5). Individual biological replicates shown (3 for wild type, spt3Δ, and sac3Δ and 2 for rad52Δ. (B) DESeq2 Linear Model 2 coefficients representing the contribution of each individual parameter to the differences in mRNA abundance of the set of genes shown in (A). DESeq2 was used to model expression as dependent on 3 categorical independent variables and 1 continuous variable (with an additional intercept factor): Genotype (wild type, spt3Δ, rad52Δ, sac3Δ), TRP1 auxotrophy (present, not present), Age (log phase, 24 hours, 48 hours), and SEP (Tom70-GFP continuous, values taken from medians shown in Figs 3A and S3C min-max scaled to the range [0,1], wild type values also used for TRP1-repaired samples). Coefficient values can be interpreted as the log2 normalised mRNA abundance change caused by a specific model factor being present relative to a wild-type log phase TRP1 auxotroph. Solid horizontal lines within violins indicate median values, while lower and upper quartiles are indicated by dotted horizontal lines. Full output of the model is provided in S2 File. (C) Log2 change of mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). Data are the mean of 3 biological replicates for wild type, spt3Δ, and sac3Δ or 2 biological replicates for rad52Δ, plots as in (C). (D) Analysis of median change in log2 mRNA abundance from log phase to given time points for all genes on ChrXIIr. Analysis by 2-way ANOVA with post hoc Tukey test for aged time-points only since log values are the reference point n = 6 biological replicates (wild type, combining wild type and TRP1 datasets), n = 3 for spt3Δ and sac3Δ, n = 2 for rad52Δ. Red p-values indicate significance at p < 0.05. (E) Percentage of the observed differential expression attributable to Age (log vs. 48 hours), SEP (Tom70-GFP), and TRP1. DESeq2 Linear Model 3 with categorical independent variables for Genotype, Age, TRP1, and carbon source, and 1 continuous variable for Tom70-GFP representing the SEP was applied to a dataset featuring 9 replicate time courses of wild-type cells aged on glucose (including 3 trp1Δ) and 5 replicate time courses of wild-type cells aged on galactose as well as the datasets for spt3Δ, sac3Δ, and rad52Δ. After excluding genes with a normalised read count <4 at log phase, percentages were calculated as the contribution from the given factor / the observed change × 100. Values outside the range 0%–100% represent model coefficients predicting gene expression in the wrong direction or of too great a magnitude, respectively. Full output of the model is provided in S3 File. (F) Assignment of gene expression change in wild type ageing log to 48 hours to SEP and Age contributions calculated by Linear Model 3, displayed as MA plots. Left–right: Observed gene expression change in wild type during ageing for average of 6 TRP1-positive wild-type samples at log phase and 48 hours; log phase expression with the SEP contribution added; log phase expression with the Age contribution added; log phase expression with the Residual contribution added, where the residual is observed gene expression change with age that was not attributed to SEP or Age by the model. Red dots indicate RNA from the IGS regions of the rDNA, which form prominent outliers. The numerical data underlying this Figure can be found in S8 File. BH, Benjamini–Hochberg; FDR, false discovery rate; SEP, senescence entry point.

We also found 290 genes significantly differentially expressed based on Age (DESeq2 48-hour versus log phase age, BH-corrected FDR < 0.05, log2-fold change threshold ± 0.5), for which Age was by far the strongest variable contributing to differential expression with little contribution from SEP or Genotype (S4A and S4B Fig). These genes are enriched for energy utilisation categories, translation, and ribosome synthesis as may be expected for ageing, given previous reports. However, the comparison of 48 hours versus log phase also compares cells that are largely terminally arrested to cells that are not, and, therefore, some fraction of these differences may be attributable to terminal arrest rather than ageing per se.

An unexpected feature of the set of genes significantly associated with the SEP was that 22% are located on the right arm of chromosome XII between the rDNA and the telomere, a region containing only 5% of annotated genes. This region, hereafter referred to as ChrXIIr, has been previously noted to be amplified during yeast ageing with unknown effect [8,16]. We therefore asked whether the expression of genes in this region was generally disrupted in aged cells and observed that average mRNA abundance for genes on ChrXIIr increased significantly with age in wild type (S4C Fig, left, S4D Fig). Although many genes are induced with age, the average mRNA abundance change of any large, random set of genes between 2 datasets should be close to zero due to the DESeq2 normalisation method applied. Indeed, an equivalent analysis for all genes not on chromosome XII shows no average change, although the spread of mRNA abundance does increase with age as expected (S4C Fig, right, S4D Fig), so the effect on ChrXIIr is exceptional. To ensure that this accumulation of ChrXIIr is not a unique feature of ageing in the diploid strains used for the MEP, we also analysed haploid MEPs by Tom70-GFP and RNA-seq and observed a similar accumulation of ChrXIIr in concert with the increasing Tom70-GFP signal (S4E and S4F Fig).

Among the mutants, increased mRNA abundance for ChrXIIr genes was less evident in spt3Δ and almost undetectable in sac3Δ, despite a similar increase in the spread of mRNA abundance (Fig 4C and 4D, compare grey to purple and orange). In contrast, average mRNA abundance for ChrXIIr genes dramatically increased in rad52Δ at 24 hours, significantly more so than in wild type (Fig 4C and 4D, compare grey to green). Expression of ChrXIIr genes closely follows the pattern of the SEP marker Tom70-GFP, showing association of ChrXIIr accumulation with the SEP across our dataset (Fig 3A).

Genes on ChrXIIr were not major contributors to the GO terms enriched in the 187 SEP-associated genes; both the enriched GO terms and the model coefficients were essentially identical when genes on ChrXIIr were excluded (S4G Fig). Therefore, these 187 genes can be split into 2 classes—those located on ChrXIIr and those functionally enriched for sporulation and iron metabolism. However, this gene set must only contain the strongest SEP-associated genes as age-linked dysregulation of gene expression and the SEP occur in all the mutants in the dataset to a greater or lesser extent, such that the linear model would have difficulty separating effects arising from the SEP and Age. We suspected that senescence may be responsible for the majority of reported age-linked gene expression changes but required data for cells that age without a detectable SEP phenotype to confirm this. We therefore added 5 replicate time courses for YDH18 yeast (which carries 2 fluorescent markers but is otherwise a wild-type MEP strain) aged on galactose to the dataset along with matched glucose controls; on galactose, wild-type MEP cells achieve equivalent age but with very low senescence [22]. We then recalculated the linear model with variables for SEP, Age, Genotype, and TRP1, and an additional variable for Carbon source (glucose or galactose). This discovered a much larger set of 1,236 genes significantly differentially expressed based on the SEP (DESeq2, BH-corrected FDR < 0.05, log2-fold change threshold ± 0.5), compared to 237 based on Age, while 657 genes were significantly differentially expressed on galactose compared to glucose (Linear Model 3, S3 File).

In this variant of the model, only SEP, Age (log versus 48 hours) and TRP1 components contribute to differential gene expression during wild type ageing on glucose. Comparing 48-hour-aged samples to log phase, the model attributes 81% of observed gene expression change to the SEP, while Age explains 24% and TRP1 explains 1% (Fig 4E). Adding the contribution of the SEP to log phase wild-type gene expression results in a gene expression pattern very similar to that observed in aged cells including the characteristic induction of repressed genes and decreased expression of highly expressed genes, particularly translation and ribosome synthesis factors (Fig 4F, compare left-hand 2 panels). In contrast, the contribution of Age barely changes the overall shape of the gene expression profile; genes significantly affected by Age are particularly enriched for cell wall organisation genes, which may result from the cell growth that occurs in all the tested mutants as well as in galactose-aged wild-type cells and is therefore independent of the SEP (Fig 4F, Age). The biggest changes in this set are the IGS ncRNAs transcribed from ERCs, as expected given the previous data showing no association between ERC accumulation and the SEP (Fig 4F, red points). Once Age and SEP are removed, only small fractions of the gene expression change during ageing from log to 48 hours remain unaccounted for (Fig 4F, Residual). Importantly, this bioinformatic separation of the impacts of the SEP and age itself paralleled the results of physical separation of younger, highly senescent and old, minimally senescent populations, which also showed the SEP to have a much larger effect than age itself (Figs 4 and S4 in [22]).

The SEP causes a massive slowing in growth that is predicted to induce an ESR-like gene expression change [5,13,66,67]. To confirm this, we compared the Age and SEP coefficients of gene expression during ageing to the change in expression of the approximately 900 ESR genes during a representative stress (20 minutes heat shock) reported in [13]. As predicted, a positive correlation was observed with the SEP (R2 = 0.68) but no correlation with Age (R2 = 0.19), showing that gene expression changes in the SEP are similar to those induced by heat shock (S5A Fig). We performed an equivalent comparison to gene expression changes that occur in response to slowing of growth [66] and also observed a correlation to the SEP (S5B Fig); the correlation was more modest (R2 = 0.52), but it should be noted that culture conditions used to control growth rate were very different from those used in our ageing experiments. To generalise these associations, we compared the Age and SEP coefficients to all the stress conditions tested in [13] and observed that the correlation was much higher for the SEP than for Age in all stresses, with the best correlation to the SEP being observed for “heat shock” and “entry to stationary phase” conditions that gave the strongest ESR response in the original study. These findings demonstrate that the gene expression impact of the SEP is similar to slow growth and the ESR and should therefore largely be attributed to slowed growth. However, the SEP does not exactly equate to an ESR since expression of the 187 SEP-associated genes discovered by Linear Model 2 (Fig 4A) does not change in the same way during heat shock as during ageing (S5D Fig), and, similarly, there is no correlation between the expression change of the 187 SEP-associated genes during ageing and during change in growth rate (S5E Fig).

Overall, we find that the SEP is by far the greatest contributor to age-linked gene expression changes. The bulk of these changes result from slowing of growth, but we also find signatures of specific gene expression programmes and chromosomal abnormalities.

ChrXIIr rather than ERC accumulation is associated with the SEP

The increased expression of genes on ChrXIIr with the SEP strongly suggested the accumulation of a chromosomal fragment from this region; indeed, a discrete chromosomal fragment arising through rDNA cleavage and containing part of the rDNA along with the chromosomal region centromere distal to the rDNA has been previously described in aged wild-type MEP cells and validated by pulsed field gel electrophoresis [8,16]. We therefore performed genome resequencing on DNA isolated from log, 24-hour, and 48 hour-aged wild type, spt3Δ, rad52Δ, and sac3Δ cells. The most dramatic change was rDNA copy number, which increased 14× with age in wild type due to ERC accumulation but not in the mutants (Fig 5A); however, in rad52Δ cells, the primary change with age was a 1.5-fold increase in ChrXIIr signal, equivalent to 1 additional copy of this region in these diploid cells (Fig 5B and 5C, left). ChrXIIr also accumulated in wild-type cells with age, but less so in spt3Δ and was almost undetectable in sac3Δ following closely the pattern we observed for SEP markers (Fig 4C), while other chromosomes did not change on average (Fig 5C, middle), and we observed little change from the rest of chromosome XII (from the left telomere to the rDNA; Fig 5C, right).

Fig 5. ChrXIIr amplification is associated with the SEP.

Fig 5

(A) Ratio of genome resequencing read counts at given time point to log phase in 5 kb windows across the rDNA. (B) Heat map of read count ratios between log phase and 48 hours in rad52Δ in 25 kb windows across the genome. (C) Ratio of genome resequencing read counts at given time point to log phase in 25 kb windows across ChrXIIr (left) and non-chromosome XII regions (right). The numerical data underlying this Figure can be found in S8 File. rDNA, ribosomal DNA; SEP, senescence entry point.

Although ChrXIIr is the most highly amplified region, other individual chromosomes also change with age albeit to a much lesser extent than ChrXIIr. We observed amplification of chromosome I and chromosome VI by both genome resequencing and RNA-seq; although these effects are small compared to ChrXIIr, we are confident the events are real given detection in different samples by different methods (S6 Fig), while other chromosomes did not show consistent changes (S4 File). These amplification events occur to a similar extent in wild type and mutants, so are unlikely to be associated with the SEP, and are probably the outcome of chromosome missegregation events previously visualised by Neurohr and colleagues using a chromosome I marker [19]; the bias towards particular chromosomes (the shortest in the genome) is interesting but not entirely unexpected as small chromosomes in yeast are more prone to aneuploidy [68].

These experiments show that increased gene expression from ChrXIIr results from amplification of this chromosomal region, which appears particularly susceptible to aneuploidy beyond the known chromosome missegregation phenotypes observed in ageing cells. Furthermore, amplification of ChrXIIr is robustly associated with the extent of senescence across wild type, spt3Δ, rad52Δ, and sac3Δ mutants.

ChrXIIr is associated with the SEP across different mutants and environments

We then tested the robustness of the association between ChrXIIr and the SEP in other mutants. rad52Δ is an outlier in our dataset, showing high SEP, high ChrXIIr, and no ERCs, whereas spt3Δ and sac3Δ follow a pattern of having low ERCs and low SEP, so it was important to ensure that senescence was unconnected to ERC level in other mutants. One concern is that rad52Δ cells arrest at a very young replicative age, usually in G2 (>80% budded at 24 hours in our samples; S7A Fig left) [25,69], whereas wild-type yeast cells typically terminally arrest in G1. Although quantitative imaging data for Tom70-GFP and other markers is filtered to include only G1 cells and should therefore be comparable between mutants, the sequencing methods are applied to whole populations, so the unusually high budded fraction may distort the outcome. We therefore looked for further mutants and conditions that separate ERC accumulation from the SEP.

Firstly, like rad52Δ, the histone deacetylase double-mutant hst3Δ hst4Δ is short lived and reaches terminal arrest by 24 hours [70] (S7B Fig, WGA). However, a smaller fraction of cells arrest in G2/S, making the cell cycle distribution of bulk samples closer to wild-type at 24 hours (60% budded for hst3Δ hst4Δ compared to 80% for rad52Δ and 40% for wild type; S7A Fig right), and ERC levels, although reduced, are much closer to wild type (S7C Fig). Nonetheless, Tom70-GFP is substantially higher than wild type at 24 hours, showing a strong early senescence phenotype (S7B Fig, Tom70-GFP), and RNA-seq at 24 hours shows a dramatic dysregulation of gene expression compared to wild type, even more so than for rad52Δ (S7D Fig). Induction of the 187 genes associated with the SEP is equivalent between hst3Δ hst4Δ and rad52Δ (S7E Fig), as is the increased expression of ChrXIIr genes, indicating an equivalent ChrXIIr amplification (S7F Fig). Therefore, SEP onset, ChrXIIr accumulation, and SEP-associated gene expression changes are very similar between hst3Δ hst4Δ and rad52Δ, whereas G2 arrest and ERC accumulation are different, meaning that the rapid, strong SEP in short-lived mutants is strongly associated with ChrXIIr accumulation and cannot be attributed to G2-biased cell cycle distribution at terminal arrest or to a peculiarity of the rad52Δ mutant.

Secondly, cells lacking the endonuclease Mus81 accumulate 10-fold fewer ERCs (Fig 6A and [71]). However, mus81Δ cells do not terminally arrest at a young age, reaching equivalent age to wild type by 24 hours and dividing further from 24 to 48 hours, even though age at 48 hours is less than wild type (Fig 6B, WGA). Furthermore, mus81Δ cells arrest less often in G2/S compared to rad52Δ cells (60% budded for mus81Δ compared to 80% for rad52Δ; Fig 6C). However, despite the lack of ERCs, mus81Δ cells accumulate similar levels of Tom70-GFP to wild type (Fig 6B, Tom70-GFP) and undergo equivalent gene expression dysregulation (S7G Fig). ChrXIIr gene expression rises similarly to wild type in keeping with Tom70-GFP intensity (Fig 6D), and induction of SEP-associated genes is also equivalent to wild type (Fig 6E). Altogether, this demonstrates that mus81Δ cells show a normal SEP profile despite a large reduction in ERC accumulation, without the strong and early induction of the SEP observed in short-lived rad52Δ an hst3Δ hst4Δ mutants, and that the SEP is again tightly associated with ChrXIIr amplification.

Fig 6. Robust association of ChrXIIr amplification with the SEP.

Fig 6

(A) Southern blot analysis of ERC abundance in log phase and 48-hour-aged wild-type and mus81Δ MEP cells; quantification shows ratio of ERC bands to chromosomal rDNA. (B) Imaging flow cytometry analysis of Tom70-GFP intensity, which increases hugely in G1 cells after the SEP [5], and for WGA, which reports on replicative age. Cells were gated for streptavidin staining (aged samples only), which filters out young cells, then for circularity, which selects towards G1 cells and removes clumps. Graph shows medians of biological replicate populations, p-values calculated from 2-way ANOVA with post hoc Tukey test using genotype and age as independent variables, n = 3. Red p-values indicate significance at p < 0.05. (C) Cell cycle stage plot comparing the percentage of budded and unbudded cells. Imaging flow cytometry was performed with gating for streptavidin (aged samples only), then budded and unbudded cells called based on circularity and validated by examining representative images. Error bars ±1 SD. (D) Log2 change of mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). Data are the mean of 3 biological replicates. (E) Hierarchical clustering of log2 mRNA abundance for 187 genes called by a DESeq2 Linear Model 2 as significantly different between datasets based on the SEP. Individual biological replicates shown (2 for each condition). (F) Plot of senescence based on Tom70-GFP versus ChrXIIr amplification (estimated from RNA-seq), for all individual wild-type samples from [22], for which matched Tom70-GFP and gene expression data are available (GSE207503 glucose, galactose, fructose, sucrose, raffinose-galactose, glucose<>galactose shifts). R2 calculated by linear regression; dotted lines show 95% confidence intervals. (G) Plot of senescence based on Tom70-GFP versus ERC accumulation (estimated from IGS2 signal at given time point–log in RNA-seq), for all individual wild-type samples from [22], for which matched Tom70-GFP and gene expression data are available (GSE207503 glucose, galactose, fructose, sucrose, raffinose-galactose, glucose<>galactose shifts). R2 calculated by linear regression; dotted lines show 95% confidence intervals. Red and blue boxes outline the 2 observable clusters of points. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; MEP, mother enrichment program; rDNA, ribosomal DNA; SEP, senescence entry point; WGA, wheat germ agglutinin.

Thirdly, to avoid peculiarities of DNA repair mutants, we asked whether ChrXIIr and/or ERC accumulation predict the SEP marker Tom70-GFP in wild-type cells aged in different conditions using the large dataset of matched RNA-seq and Tom70-GFP data from [22]. A plot of ChrXIIr accumulation versus Tom70-GFP across all datasets reveals a very good correlation (R2 = 0.84) (Fig 6F), showing that ChrXIIr is tightly associated with the SEP. The same dataset can also be used to examine ERCs as the change in reverse strand signal from ncRNA in the IGS2 region efficiently reports ERC accumulation (compare S2A with S1B Fig; also compare Fig 5A and 5B in [22]), providing a proxy for ERC accumulation in RNA-seq data. As expected, given our RNA-seq analysis, we observe less correlation between ERC accumulation and Tom70-GFP (R2 = 0.47), and closer inspection reveals that the data are subdivided in 2 sets—a low Tom70-GFP set with a wide spectrum of ERC levels, and a high IGS expression set with a wide spectrum of Tom-70 GFP signal (Fig 6G, red and blue, respectively)—in each of which there is essentially no correlation between ERCs and Tom70-GFP.

Finally, the particularly strong SEP phenotype of the rad52Δ mutant, as well as its profound DNA repair deficit, could result in the rad52Δ dataset having an undue influence in our linear models wherein we find an association between the SEP and the ChrXIIr chromosomal abnormality. To address this concern, we refitted Linear Models 2 and 3 including data for wild type, spt3Δ, and sac3Δ but without the rad52Δ dataset (S5 and S6 Files). Reassuringly, most genes significantly differentially expressed based on the SEP variable in the original models were still significantly differentially expressed when the rad52Δ data were excluded (78% of genes in Model 2 and 90% of genes in Model 3). Furthermore, genes significantly differentially expressed based on the SEP were still strongly overrepresented on ChrXIIr but not on other chromosomes when rad52Δ was excluded from the analysis, showing that the association of ChrXIIr with the SEP is maintained (S8A Fig). Quantitatively, individual coefficients from Model 3 fitted without the rad52Δ dataset were very similar to the original model (median difference in Age coefficient 0.02 ± 0.03 SD, SEP coefficient 0.04 ± 0.09 SD), and, unsurprisingly, plots of these components are almost identical to those from the model fitted with the full dataset (compare S8B Fig to Fig 4F). Although the component of IGS transcription attributed to the SEP by the model lacking the rad52Δ dataset is higher than in the original model, this is still minor compared to the component associated with Age; this means that ERC amplification is still primarily associated with age rather than SEP onset (S8B Fig, red dots). These tests clearly demonstrate that our findings are not dependent on the dataset from the rad52Δ mutant.

ChrXIIr amplification is therefore robustly associated with the SEP across many mutants and environments, whereas ERCs are not, showing that ChrXIIr accumulation is a major feature of senescence.

Amplification of protein coding genes on ChrXIIr does not cause senescence

ChrXIIr can be imagined in 2 parts—a tract of rDNA repeats of variable size from 0 to 1.8 Mb depending on where within the rDNA the cleavage occurs that forms ChrXIIr, attached to a region of 0.6 Mb containing 334 annotated genes (Fig 7A, schematic). We considered 2 potential mechanisms by which accumulation of such a noncentromeric chromosome fragment could contribute to the SEP. The dysregulation of expression of the 334 genes caused by the imbalance in gene copy number could result in widespread defects in protein complement [72], or alternatively, the presence of a large noncentromeric chromosomal fragment could itself impair the cell cycle irrespective of gene content. Of course, across the spectrum of age-linked pathology, these explanations may not be mutually exclusive.

Fig 7. Increased copy number of genes telomere proximal to the rDNA on ChrXII is not responsible for the SEP.

Fig 7

(A) Schematic showing different possible sizes of ChrXIIr and relative contributions from other regions of Chromosome XII. (B) Schematic of translocation strategy for fusing gene-containing portion of ChrXIIr to chromosome V. (C) Log2 change of normalised mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). (D) Plots of Tom70-GFP and WGA intensity with cell size gated as in Fig 3 for wild type and chromosome XIIr <> V translocation strain. The numerical data underlying this Figure can be found in S8 File. rDNA, ribosomal DNA; SEP, senescence entry point; WGA, wheat germ agglutinin.

To determine whether dysregulation of the 334 genes on ChrXIIr is associated with the SEP, we engineered a translocation that relocated the gene-containing 0.6 Mb section of ChrXIIr to chromosome V and terminated chromosome XII with a telomere adjacent to the rDNA, forming the XIIr <> V strain (Figs 7B and S9A). This should prevent the amplification of the 334 genes, but not impede the amplification of the variable length rDNA-containing segment, such that a ChrXIIr-like species can still form but containing only the rDNA tract without the protein-coding genes. For reasons that remain unclear, we were unable to generate this translocation in the α haploid and therefore generated a:a diploids of both the wild-type control strain and the strain carrying the XIIr <> V translocation. The increase in ChrXIIr gene mRNAs that occurs with age in wild type was dramatically reduced in the XIIr <> V strain, which is as expected since these genes are no longer present on the ChrXIIr fragment accumulated after rDNA cleavage (Fig 7C). Nonetheless, the increase in Tom70-GFP signal with age and the growth in cell size occurred just as in wild type (Fig 7D), while global gene expression dysregulation and change in expression of the SEP-linked genes defined in Fig 4A occurred just as in the control strain (S9B and S9C Fig). This experiment clearly shows that although the SEP is associated with amplification of ChrXIIr, the SEP does not require amplification of specific genes on ChrXIIr. In other words, amplification of centromere distal genes to the rDNA does not cause senescence; instead, this is presumably associated with the formation of the large linear rDNA component of the ChrXIIr fragment.

Overall, our results are entirely consistent with models that predict defects in rDNA stability to be potent drivers of ageing and age-linked phenotypes. However, we find no evidence that ERCs have any impact on the physiology of aged cells; rather, the formation of a noncentromeric fragment encompassing the region between the rDNA and the right telomere of chromosome XII is associated with the SEP and is a strong candidate for mediating the damaging effects of ageing in yeast.

Discussion

ERCs were first proposed as a cause of yeast ageing over 20 years ago, based on strong accumulation in short-lived mutants and the life span reduction caused by artificial ERCs [24]. However, the mechanism of ERC toxicity remains unknown, and though recent studies linked defects in ribosome synthesis and nuclear pore structure to ERC accumulation, it is unclear whether or how these affect ageing cell physiology [19,20,49,50]. Here, we examined ageing phenotypes in a panel of low-ERC mutants and found that age-associated transcriptomic dysregulation and the SEP occur independently of ERCs. Furthermore, we did not find any robust indication of pathway-specific impacts of ERCs at the gene expression level. ERCs are therefore not necessary for age-associated phenotypes in yeast, and in the accompanying manuscript, we show that ERCs are also not sufficient as cells aged for 48 hours on galactose have plentiful ERCs but minimal age-associated phenotypes [22]. These findings are incompatible with the hypothesis that ERCs are a primary driver of age-related changes in S. cerevisiae. Instead, we show that another rDNA-derived extrachromosomal species is tightly associated with the SEP and may be a major contributor to age-related phenotypes in normal yeast cells.

ChrXIIr as a candidate mediator of ageing phenotypes in yeast

Substantial effort has been invested in understanding the mechanism by which ERC accumulation can cause ageing. Given that ChrXIIr levels are much more tightly associated with the SEP than ERC levels, we asked whether these mechanisms could be adapted to explain how ChrXIIr present at approximately 1 molecule per cell might induce age-linked phenotypes. Recent studies have identified ultrastructural changes in the nuclear pore and nuclear pore complex impairment as causes of ageing phenotypes in yeast, arising through binding of ERCs to nuclear pores [49,50]. We propose that large linear acentromeric DNA fragments also bind nuclear pore complexes by the same SAGA/TREX-2-mediated mechanism as ERCs but due to their size would link together and entangle many nuclear pore complexes, thereby impairing nuclear membrane structure (Fig 8). Interestingly, this recapitulates the pathogenic mechanism that underlies accelerated ageing in HGPS, which involves disruption of nuclear membrane architecture, linking ageing mechanisms in yeast and humans [73].

Fig 8. Hypothesised mechanism for pathological activity of ChrXIIr.

Fig 8

A single copy of ChrXIIr is bound through SAGA and TREX-2 to many nuclear pore complexes. As ChrXIIr undergoes conformational changes and random motion, this will exert forces that act to deform the nuclear membrane leading to the observed defects in nuclear membrane structure [50]. This will also restrict any required redistribution and relaxation of nuclear pore complexes within the nuclear membrane, and ChrXIIr binding would be expected to induce the same gradual impairment of nuclear pore structure and function attributed to ERCs [49].

This mechanism should be largely independent of the sequence composition of the DNA fragments, being simply driven by large fragment size. This explains why translocation of the 600-kb centromere distal region from Chromosome XII did not prevent the SEP as rDNA cleavage events would still form linear acentromeric DNA fragments of up to 1.8 Mb (Fig 7C), and the defects caused per molecule would not be much different. Others have shown that synthetic ERCs can cause life span and nuclear pore defects, although rDNA sequences themselves are dispensable [24,49,74]; it is likely that small circular DNAs the size of a single ERC could entangle a few nuclear pores, causing a pathogenic phenotype if present at sufficient levels, but the model we propose predicts that these would be far less disruptive than a much smaller number of very large linear molecules such as ChrXIIr. It remains unknown why ERCs bind to nuclear pore complexes, whereas chromosomal rDNA repeats seemingly do not, though one possibility is that this interaction occurs for all rDNA copies but is disrupted by chromosome condensation, which requires a centromere [75]. As ERCs and ChrXIIr lack centromeres, both species would remain bound to nuclear pore complexes into mitosis, whereas full-length chromosome XII would not; in support of this idea, condensin mutants show a specific retention of chromosome XII in the mother cell along with ERCs [76].

Defects in nuclear pore complexes and nuclear membrane structure would be expected to cause nonspecific changes in mRNA export and gene expression, rather than impacting particular sets of genes, and such changes would be invisible to bulk RNA-seq methods. Dysregulation of gene expression would impair the precise biochemical control that facilitates rapid growth, slowing the cell cycle, which, in turn, would cause a change in the global expression profile as cells alter gene expression suitably for the reduced growth rate. This explains our finding that many of the gene expression changes previously attributed to replicative ageing are more specifically a consequence of the SEP, with post-SEP cells displaying a highly dysregulated gene expression pattern that resembles the effect of slow growth.

It seems reasonable to suggest that prolonged time in the SEP with high levels of nuclear pore complex and nuclear membrane disruption will eventually render cells inviable, either due to gene expression pattern being disrupted beyond tolerable parameters or due to known impacts of nuclear membrane structure defects on DNA replication (Fig 8). Either effect could explain the early terminal arrest of rad52Δ and hst3Δ hst4Δ cells. In general, however, our data do not support the SEP being the primary life-limiting process in normal yeast ageing: Nonsenescent galactose-aged cells have a similar life span to cells aged on glucose which do senesce; nonsenescent sac3Δ cells are short lived; and Li and colleagues have described a SEP-free ageing trajectory by microfluidics [23]. Therefore, ChrXIIr is tightly associated with senescence and poorly with life span, making ChrXIIr a candidate mediator of age-linked phenotypes but not a life span limiter except perhaps in extreme cases.

The ERC model of yeast ageing has been remarkably effective in predicting and explaining yeast mutants with altered life spans. However, these outcomes are difficult to translate to higher eukaryotes where evidence for ERC accumulation in ageing is lacking. Our findings suggest that other, lower copy number extrachromosomal DNA species could be potent mediators of ageing phenotypes, driving differences in ageing health almost independent of life span. Of course, it is not yet proven that the appearance of ChrXIIr always triggers SEP onset, so we cannot rule out the possibility that ChrXIIr formation is a consequence rather than a cause of the SEP. However, non-centromeric fragments have the potential to mediate long-term phenotypic effects of ageing and could arise through age-linked rDNA cleavage in higher eukaryotes, raising the prospect of an rDNA stability mechanism of ageing pathology conserved from yeast to mammals.

ChrXIIr accumulation can substitute for ERCs in many models of ageing

The accumulation of ChrXIIr first reported by Hu and colleagues is likely to be affected by the vast majority of the mutants used to modulate ERC levels, though mechanistic dependencies for ChrXIIr and ERCs are not identical. The relationship between ERCs and ageing has been previously questioned by Ganley and colleagues who demonstrated that reducing the efficiency of rDNA replication origins not only decreased ERC abundance but also decreased life span and rDNA stability [77]; we note that irrespective of the effect on ERCs, reducing origin efficiency would increase the chance that rDNA replication is not completed in a timely fashion and accelerate ChrXIIr formation, driving an early very strong SEP. Similarly, the ChrXIIr model can resolve the long-standing issue of why homologous recombination mutants are short lived despite having no ERCs, since ChrXIIr formation should be accelerated when homologous recombination is not available to repair stalled replication forks, likely leading to early terminal arrest through an unusually strong SEP [25].

Three recent studies have indicated that ERCs cause the SEP, which must be resolved if the ChrXIIr model is correct: Morlot and colleagues showed that the timing of ERC accumulation above background immediately precedes SEP onset [20]. However, this was only observed on average, with many individual cells showing ERC accumulation long before or long after the SEP. The risk of rDNA replication problems is known to increase with age, and we suspect that these defects are the source of both ChrXIIr and accumulated ERCs [52]. Under this model, ERC accumulation and SEP onset caused by ChrXIIr would be coincident on average because they arise through the same underlying mechanism. Neurohr and colleagues showed that the senescence phenotype can transfer to daughter cells along with all ERCs during occasional catastrophic missegregation events [19]. However, given that the mother cell retention mechanism of ChrXIIr is probably the same as for ERCs, ChrXIIr would probably have been transferred to the daughter with the ERCs. Indeed, the Cfi1 marker used in this study would not distinguish ChrXIIr from ERCs. Finally, Li and colleagues reported nucleolar expansion and fragmentation, which is thought to result from ERC accumulation [23]. However, we now show that nucleolar expansion occurs independently of ERCs (S3E Fig) so cannot be taken as evidence of a contribution of ERCs to senescence. Therefore, the similar biogenesis and segregation behaviour of ChrXIIr means that ChrXIIr could underlie many effects previously attributed to ERCs.

A mechanism for ChrXIIr formation

Much of the evidence connecting ERCs to ageing derives from mutations that increase or decrease ERC levels in young cells. However, these mutants are not absolutely specific, and those that impact rDNA recombination will also affect the formation of other nonchromosomal DNA species, including ChrXIIr. Many studies have attributed rDNA instability and ERC formation to replication fork stalling at the Fob1-mediated RFB, and SEP onset does not occur in approximately 70% of haploid fob1Δ cells [20,26,3133,78,79]. If ChrXIIr causes the SEP, then formation must be promoted by Fob1. However, an alternative Fob1-independent pathway must also exist since approximately 30% of fob1Δ cells also undergo the SEP accompanied by strong ERC accumulation [20]. Given that we detect no difference in ERC abundance between aged wild type and fob1Δ, this Fob1-independent pathway may well be dominant in diploid MEP cells, so any mechanism for ChrXIIr formation must feature Fob1 but as a contributor rather than an indispensable component. Fob1 also promotes, but is not required for, loss of heterozygosity events at ChrXIIr that increase with age in diploid MEPs [52].

Mechanistically, Fob1 blocks the passage of replication forks that would otherwise encounter the 35S RNA polymerase I transcription unit head-on (S10Aii Fig), which are then resolved by replication forks travelling codirectionally with RNA polymerase I. However, if the codirectional fork becomes unrecoverably stalled, then replication is not completed and a stable unreplicated structure would remain (S10Aiii Fig). DNA replication in yeast can continue into anaphase, at which point this structure would become stretched between 2 mitotic spindles to form a bridging chromosome (S10Aiv Fig); indeed, single-stranded rDNA intermediates have been directly observed to persist into anaphase in aged yeast [19]. DNA replication in yeast can continue into anaphase, at which point this structure would become stretched between 2 mitotic spindles to form a bridging chromosome [8082] (S10Aiv Fig). The replication fork structures must then be cleaved to allow completion of mitosis, as observed in mammalian systems [80,8385], forming the ChrXIIr fragment as well as a truncated chromosome XII (S10Av Fig). Under this model, ChrXIIr forms through cleavage of replication intermediates that remain unresolved at anaphase, rather than through specific recombination events.

Replication fork stalling at the RFB does not occur in fob1Δ, but it is likely that head-on collisions with RNA polymerase I would also cause unrecoverable fork stalling with the same outcome at a substantial frequency. Conversely, we predict that the frequency of unrecoverable stalling of replication forks in the rDNA would increase in a rad52Δ mutant as homologous recombination often rescues stalled replication forks [86,87], so ChrXIIr formation would occur more often and earlier during ageing in homologous recombination-deficient mutants. This would explain why the SEP phenotype is stronger in homologous recombination mutants than in wild type despite a complete lack of ERCs.

The ChrXIIr formation mechanism can also result in loss of heterozygosity in diploid cells (S10B Fig). If the intact chromosome XII segregates to the daughter after cleavage, the 2 cleaved chromosome XII fragments would remain in the mother cell to be repaired by single-strand annealing in the next cell cycle (S10B Fig, left outcome) [88]. However, if the centromeric fragment of the cleaved chromosome XII segregates to the daughter nucleus, it becomes physically separated from the ChrXIIr fragment, which is not under tension and will be recruited to nuclear pores in the mother nucleus [89] (Fig 8). This results in loss of heterozygosity for the daughter cell and ChrXIIr accumulation in the mother cell. Therefore, loss of heterozygosity events can be mechanistically linked to ChrXIIr formation and the SEP.

In summary, although ERC accumulation does not explain entry to the SEP, formation of another rDNA-derived species ChrXIIr is robustly associated with the SEP and provides a potential mechanism for the onset of senescence during ageing in yeast. Moreover, in tandem with [22], we find that most of the gene expression changes canonically associated with yeast ageing are actually an outcome of senescence rather than replicative age per se.

Materials and methods

Detailed and updated protocols are available at https://www.babraham.ac.uk/our-research/epigenetics/jon-houseley/protocols.

Yeast culture and labelling

Yeast strains were constructed by standard methods and are listed in S1 Table, oligonucleotide sequences are given in S2 Table, and plasmids in S3 Table. For chromosome V <> XII translocation, Tom70-GFP was first tagged with GFP in MEP a using a variant of pFA6a-GFP-KanMX6 in which the I-SceI site had been removed by site directed mutagenesis using oligos oJH1819-20, then ade2Δ was reverted by transforming with an ADE2 fragment from BY4741 to form YJH1581. The Kan resistance gene in inducible I-SceI plasmid pGSKU [90] (SacI-BmgBI fragment) was replaced with the TRP1 marker from pFA6a-TRP1 [91] (SacI-SmaI fragment) to form pGSTU. Then, a 2-kb fragment of chromosome V with an I-SceI site in the middle was inserted into pGSTU, using PCRs with oligos oJH1798-9 (SacI-BamHI) and oJH1800-1 (SacII-BamHI), and SacI SacII digested pGSTU to form pGST-V-U. The PCR product oJH1808-9 on this plasmid was transformed into YJH1581 to give yJH1585 and also into the MEP a haploid to form YJH1559. Colonies of YJH1585 and YJH1559 were restreaked twice on YPGalactose plates before screening colonies by PCR for reciprocal transformations and confirmation by PFGE (0.5× TBE, 1% gel, 60- to 120-second switching, 6 V/cm, 14°C, 24 hours), forming YJH1594 and YJH1560. The NatMX6 markers in YJH1584 and YJH1594 were replaced with His3MX6, forming YJH1703 and YJH1704. YJH1703 was mated to YJH1559, while YJH1704 was mated to YJH1560, and a:a diploids YJH1725 and YJH1726 were selected on YPD Kan Nat plates.

All cells were grown in YPD media (2% peptone, 1% yeast extract, 2% glucose) at 30°C with shaking at 200 rpm. Media components were purchased from Formedium, and media was sterilised by filtration. MEP experiments were performed as described with modifications [15]: Cells were inoculated in 4 ml YPD and grown for 6 to 8 hours and then diluted in 25 ml YPD and grown for 16 to 18 hours to 0.2 to 0.6 × 107 cells/ml in 50 ml Erlenmeyer flasks. 0.125 × 107 cells per aged culture were harvested by centrifugation (15 seconds at 13,000g), washed twice with 125 μl PBS, and resuspended in 125 μl of PBS containing approximately 3 mg/ml Biotin-NHS (Pierce 10538723). Cells were incubated for 30 minutes on a wheel at room temperature, washed once with 125 μl PBS, and resuspended in 125 μl YPD, then inoculated in 125 ml YPD at 1 × 104 cells/ml in a 250-ml Erlenmeyer flask (FisherBrand FB33132) sealed with Parafilm. 1 μM β-estradiol (from stock of 1 mM Sigma E2758 in ethanol) was added after 2 hours for wild type and spt3Δ, 3 hours for sac3Δ and mus81Δ, and 4 hours for rad52Δ and hst3Δ hst4Δ. An additional 0.125 × 107 cells were harvested from the log phase culture, while biotin labelling reactions were incubating at room temperature. Cells were harvested by centrifugation for 1 minute, 4,600 rpm, immediately fixed by resuspension in 70% ethanol, and stored at −80°C. To minimise fluorophore bleaching during Tom70-GFP experiments, the window of the incubator was covered with aluminium foil, lights on the laminar flow hood were not used during labelling, and tubes were covered with aluminium foil during biotin incubation.

Cell purification

Percoll gradients (1 to 2 per sample depending on harvest density) were formed by vortexing 900 μl Percoll (Sigma P1644) with 100 μl 10× PBS in 2 ml tubes and centrifuging 15 minutes at 15,000g, 4°C. Ethanol-fixed cells were defrosted and washed with 1 volume of cold PBSE (PBS + 2 mM EDTA) before resuspension in approximately 100 μl cold PBSE per gradient and layering on top of the preformed gradients. Gradients were centrifuged for 4 minutes at 2,000g, 4°C, and then the upper phase and brown layer of cell debris were removed and discarded. 1 ml PBSE was added, mixed by inversion, and centrifuged 1 minute at 2,000g, 4°C to pellet the cells, which were then resuspended in 1 ml PBSE per time point (reuniting samples that were split across 2 gradients). 25 μl Streptavidin microbeads (Miltenyi Biotech 1010007) were added and cells incubated for 5 minutes on a wheel at room temperature. Meanwhile, 1 LS column per sample (Miltenyi Biotech 1050236) was loaded on a QuadroMACS magnet and equilibrated with cold PBSE in a 4°C room. Cells were loaded on columns and allowed to flow through under gravity, washed with 1 ml cold PBSE, and eluted with 1 ml PBSE using plunger. Cells were reloaded on the same columns after re-equilibration with approximately 500 μl PBSE, washed and reeluted, and this process repeated for a total of 3 successive purifications. After addition of Triton X-100 to 0.01% to aid pelleting, cells were split into 2 fractions in 1.5 ml tubes, pelleted 30 seconds at 20,000g, 4°C, frozen on N2, and stored at −70°C.

For live purification, cells were pelleted, washed twice with synthetic complete 2% glucose media, then resuspended in 2 ml final volume of the same media and incubated for 5 minutes on a rotating wheel with 10 μl MyOne streptavidin magnetic beads (Thermo), isolated using a magnet and washed 5 times with 1 ml of the same media. For colony formation assays, cells were streaked on a YPD plate and individual cells moved to specific locations using a Singer MSM400 micromanipulator. Colony size was measured 24 hours later on the screen of the micromanipulator imaging with a 4× objective.

DNA extraction and Southern blot analysis

Cell pellets were resuspended in 50 μl 0.34 U/ml lyticase (Sigma L4025) in 1.2 M sorbitol, 50 mM EDTA, and 10 mM DTT and incubated at 37°C for 45 minutes. After centrifugation at 1,000g for 5 minutes, cells were gently resuspended in 80 μl of 0.3% SDS, 50 mM EDTA, and 250 μg/ml Proteinase K (Roche 3115801) and incubated at 65°C for 30 minutes. 32 μl 5 M KOAc was added after cooling to room temperature; samples were mixed by flicking and then chilled on ice for 30 minutes. After 10-minute centrifugation at 20,000g, the supernatant was extracted into a new tube using a cut tip; 125 μl phenol:chloroform (pH 8) was added, and samples were mixed on a wheel for 30 minutes. Samples were centrifuged for 5 minutes at 20,000g; the upper phase was extracted using cut tips and precipitated with 250 μl ethanol. Pellets were washed with 70% ethanol, air-dried, and left overnight at 4°C to dissolve in 20 μl TE. After gentle mixing, 10 μl of each sample was digested with 20 U XhoI (NEB) for 3 to 6 hours in 20 μl 1× CutSmart buffer (NEB), 0.2 μl was quantified using PicoGreen DNA (Life Technologies), and equivalent amounts of DNA separated on 25 cm 1% 1× TBE gels overnight at 90 V. Gels were washed in 0.25 N HCl for 15 minutes, 0.5 N NaOH for 45 minutes, and twice in 1.5 M NaCl, 0.5 M Tris (pH 7.5) for 20 minutes before being transferred to 20 × 20 cm HyBond N+ membrane in 6× SSC. Membranes were probed using random primed probes to the rDNA intergenic spacer region in 10 ml UltraHyb (Life Technologies) at 42°C and washed with 0.1× SSC 0.1% SDS at 42°C, or probed in Church Hyb at 65°C and washed with 0.5× SSC 0.1% SDS at 65°C. Images were obtained by exposure to phosphoimaging screens (GE), developed using a FLA 7000 phosphoimager (GE), and quantified using ImageQuant v7.0 (GE). Fig 6A was probed with a biotin-labelled RNA probe to the rDNA intergenic spacer region in 10 ml UltraHyb (Life Technologies) at 42°C and washed with 0.1× SSC 0.1% SDS at 42°C before hybridising with IRDye 680LT Streptavidin (LI-COR) and scanning on an Odyssey DLx (LI-COR). The Pulsed Field Gel in S9 Fig was run on a CHEF DRIII machine (Bio-Rad) using conditions: 0.5× TBE, 1% agarose, 60- to 120-second switch time, 6 V/cm, 14°C, 24 hours run time, then blotted and probed as above using a random primed probe against the BNA5 gene. Full blot images are presented in S1 Raw Images.

RNA extraction and RNA-seq library preparation

Cells were resuspended in 50 μl Lysis/Binding Buffer (from mirVANA kit, Life Technologies AM1560), and 50 μl 0.5 μm zirconium beads (Thistle Scientific 11079105Z) added. Cells were lysed with 5 cycles of 30-second 6,500 ms−1/30-second ice in an MP Fastprep bead beater or for 3 minutes at power 12 in a Bullet Blender (Thermo Fisher) in cold room, then 250 μl Lysis/Binding buffer added followed by 15 μl miRNA Homogenate Additive, and cells were briefly vortexed before incubating for 10 minutes on ice. 300 μl acid phenol:chloroform was added, vortexed, and centrifuged 5 minutes at 13,000g, room temperature before extraction of the upper phase. 400 μl room temperature ethanol and 2 μl glycogen (Sigma G1767) were added and mixture incubated for 1 hour at −30°C before centrifugation for 15 minutes at 20,000g, 4°C. The pellet was washed with cold 70% ethanol and resuspended in 10 μl water. 1 μl RNA was glyoxylated and analysed on a BPTE mini-gel, and RNA was quantified using a PicoGreen RNA kit (Life Technologies R11490) or Qubit RNA HS Assay Kit.

150 ng RNA was used to prepare libraries using the NEBNext Ultra II Directional mRNAseq kit with poly(A)+ purification module (NEB E7760, E7490) as described with modifications: Reagent volumes for elution from poly(T) beads, reverse transcription, second strand synthesis, tailing, and adaptor ligation were reduced by 50%; libraries were amplified for 13 cycles using 2 μl each primer per 50 μl reaction before 2 rounds of AMPure bead purification at 0.9× and elution in 11 μl 0.1× TE prior to quality control using a Bioanalyzer HS DNA ChIP (Agilent) and quantification using a KAPA Library Quantification Kit (Roche).

DNA extraction and library preparation for genome resequencing

Cells were resuspended in 60 μl PFGE wash buffer (10 mM Tris HCl (pH 7.5), 50 mM EDTA) with 1 μl lyticase (17 U/ μl in 10 mM KPO4 (pH 7), 50% glycerol, Merck >2,000 U/mg L2524), heated to 50°C for 2 minutes before addition of 40 μl molten CleanCut agarose (Bio-Rad 1703594), vortexing vigorously for 5 seconds before pipetting in plug mould (Bio-Rad 1703713), and solidifying 15 to 30 minutes at 4°C. Each plug was transferred to a 2-ml tube containing 500 μl PFGE wash buffer with 10 μl 17 U/μl lyticase and incubated 3 hours at 37°C. Solution was replaced with 500 μl PK buffer (100 mM EDTA (pH 8), 0.2% sodium deoxycholate, 1% sodium N-lauroyl sarcosine, 1 mg/ml Proteinase K) and incubated overnight at 50°C. Plugs were washed 4 times with 1 ml TE for 1 to 2 hours at room temperature with rocking; 10 mM PMSF was added to the second and third washes from 100 mM stock (Merck 93482). For 15 minutes, ½ plugs were equilibrated with 1 ml agarase buffer (10 mM Bis-Tris–HCl, 1 mM EDTA (pH 6.5)) and then the supernatant removed and 50 μl agarase buffer added. Plugs were melted for 20 minutes at 65°C, transferred for 5 minutes to a heating block preheated to 42°C, 1 μl β-agarase (NEB M0392S) was added and mixed by flicking without allowing sample to cool, and incubation continued at 42°C for 1 hour. DNA was ethanol precipitated with 25 μl 10 M NH4OAc, 1 μl GlycoBlue, and 330 μl of ethanol and resuspended in 130 μl 0.1× TE. DNA was fragmented in an AFA microTUBE (Covaris 520045) in a Covaris E220 duty factor 10, PIP 175, Cycles 200, Temp 11°C and then ethanol precipitated. 10 ng DNA was used to prepare libraries using the NEBNext Ultra II DNA kit (NEB E7645S) as described with modifications: Reagent volumes for tailing and adaptor ligation were reduced by 75%; libraries were amplified for 9 cycles using 2 μl each primer per 50 μl reaction before 2 rounds of AMPure bead purification at 0.9× and elution in 11 μl 0.1× TE prior to quality control using a Bioanalyzer HS DNA ChIP (Agilent) and quantification using a KAPA Library Quantification Kit (Roche).

Sequencing

DNA- and RNA-seq libraries were sequenced by the Babraham Institute Sequencing Facility using a NextSeq 500 instrument on 75 bp single end mode. All RNA-seq data have been deposited at GEO under accession numbers GSE207429 and GSE207503.

RNA-seq QC, mapping, quantification, and analysis

FASTQ format files provided by the Babraham Institute Sequencing Facility were processed to integer read counts per gene using a Nextflow (v20.01.0) pipeline slightly modified from the RNA-seq pipeline provided by nf-core (v1.4.2) [92,93]. Reads were adapter and quality trimmed using Trim Galore! (v0.6.5) (www.bioinformatics.babraham.ac.uk/projects/trim_galore) wrapper around Cutadapt (v2.10) [94]. Libraries were then assessed for overall quality using FastQC (v0.11.9) (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Reads were mapped to the R64-1-1 S. cerevisiae genome assembly using HISAT2 (v2.2.0) [95,96]. Mapped reads were quantified over exons and grouped at the gene_id level using featureCounts (v2.0.0) [97]. For mapping and quantification, we used ENSEMBL release 99 annotation augmented with 4 additional loci between the canonical RNA Polymerase I–transcribed rRNA genes. The following were annotated with the “rDNA_intergenic” gene biotype: IGS2-1S at XII: 485433–459675,—strand; IGS2-1AS at XII: 458433–459675, + strand; IGS1-2S at XII: 459797–460711,—strand; IGS1-2AS at XII: 459797–460711, + strand. For downstream analyses, we included all genes with annotated gene_biotype: “protein_coding,” “transposable_element,” or “rDNA_intergenic.” We excluded all mitochondrially encoded genes and those around the rDNA locus (i.e., with start or end positions within XII: 450000–491000) apart from ones with the “rDNA_intergenic” biotype. We performed most RNA-seq data manipulations downstream of featureCounts in the R (v4.2.1) programming environment [98]. We made significant use of the Tidyverse (v1.3.1) family of packages [99], particularly stringr (v1.4.0), dplyr (v1.0.9), purrr (v0.3.4), tidyr (v1.2.0), readr (2.1.2), and tibble (v3.1.7). The DESeq2 (v1.36.0) [55] package was obtained from the Bioconductor repository using BiocManager (v3.15) [100].

RNA-seq normalisation, differential expression testing, and graphical output

In general, we used the built-in DESeq2 size factor normalisation process to make values comparable across sequenced libraries for visualisation as well as for differential expression testing. We applied a BH-corrected FDR cutoff of 0.05 for all differential expression tests. We categorised genes with log2 fold-change > 0.5 as significantly up-regulated and genes with log2 fold-change < −0.5 as significantly down-regulated. For display, we log2 transformed normalised read counts using an added pseudocount of 1 to deal with any instances of 0 detected counts.

The lists of significantly differentially expressed genes for S1C and S2A Figs were derived from a fitted DESeq2 model with Age (categorical, levels: log phase, 48 hours) as a single design factor. This included log phase and 48-hour-aged samples in triplicate from the wild-type background. Pairwise comparisons mentioned in section “ERC accumulation exerts minimal effects on individual genes” were performed using fitted DESeq2 models comparing 48-hour-aged samples of wild type (triplicate) with spt3Δ (triplicate), rad52Δ (duplicate), or sac3Δ (triplicate) using Genotype (categorical, levels: wild type, mutant) as the single design factor.

Displayed data for Fig 2C as well as the list of genes displayed in heatmap 2B was derived from a fitted DESeq2 model with Age (categorical, levels: log phase, 24 hours, 48 hours), Genotype (categorical, levels: wild type, spt3Δ, rad52Δ, and sac3Δ), ERC abundance (categorical, levels: low, high), and TRP1 (categorical, levels: absent, present). This included log phase, 24-hour, and 48-hour-aged samples in triplicate for wild type, TRP1-repaired wild type, spt3Δ, and sac3Δ as well as in duplicate for rad52Δ. For the ERC abundance factor, most samples were classified as “low,” while wild type (including TRP1-repaired wild type) 24-hour and 48-hour aged samples were “high.” For the TRP1 factor, wild-type cells had the marker “absent,” while all others (including TRP1-repaired wild types) had the marker “present.” The full set of linear model log2-fold change coefficients and DESeq2 results are in S1 File.

For analysis of SIR complex-regulated genes, we considered genes to be regulated by the SIR complex if they were determined to be differentially expressed (under the original authors definition) in sir2Δ, sir3Δ, and sir4Δ backgrounds by Ellahi and colleagues (bolded entries in Table 7 from that publication). There were 40 of 42 genes present in our filtered RNA-seq dataset.

Displayed data for Figs 4B, 4C, 4D, S4A, S4B, S4C and S4D as well as the list of genes displayed in Figs 4A, S4A, S6E, and S8C was derived from a fitted DESeq2 model with Age (categorical, levels: log phase, 24 hours, 48 hours), Genotype (categorical, levels: wild type, spt3Δ, rad52Δ, and sac3Δ), TRP1 (categorical, levels: present, absent), and SEP status (continuous, values min-max scaled to the range [0,1]). Data included as for the previous linear model. TRP1 categorised as above. Values for SEP status taken from TOM70-GFP medians shown in Figs 3A and S3C with wild type values also used for TRP1-repaired samples. The full set of linear model log2-fold change coefficients and DESeq2 results are in S2 File, while equivalent information for the modified version fitted with the rad52Δ dataset is in S5 File.

Displayed data for Fig 4E and 4F were derived from a fitted DESeq2 model with Age (categorical, levels: log phase, 24 hours, 48 hours), Genotype (categorical, levels: wild type, spt3Δ, rad52Δ, and sac3Δ), TRP1 (categorical, levels: present, absent), SEP status (continuous, values min-max scaled to the range [0,1]), and Carbon source (categorical, levels: glucose, galactose). All previously used data were included as described above and with the “glucose” Carbon source. Additionally, we included 5 sets of log phase, 24-hour, and 48-hour samples of YDH18 cells grown on glucose and 6 sets of the same grown on galactose (data originally from [22]). These were considered to be of the wild-type genotype for modelling due to the negligible genotypic and phenotypic differences. They also had the TRP1 marker “present.” SEP values for used for wild types in the above model were used for glucose-grown DH18 samples. SEP values for galactose-grown DH18 samples were taken from Fig 1B in [22]. The full set of linear model log2-fold change coefficients and DESeq2 results are in S3 File, while equivalent information for the modified version fitted with the rad52Δ dataset is in S6 File.

Displayed RNA-seq data for Figs 1C, 2B, 2D, 4A, S4A and S5E were adapter and quality trimmed using Trim Galore (v0.6.6) and were mapped to yeast genome R64-1-1 using HISAT2 v2.1.0 [96] by the Babraham Institute Bioinformatics Facility. Mapped data were imported into SeqMonk v1.47.0 (https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/) and quantified for log2 total reads mapping to the antisense strand of annotated open reading frames (opposite strand-specific libraries) with probes included to each strand of the rDNA intergenic spacer regions. Read counts were adjusted by size factor normalisation for the full set of quantified probes.

Hierarchical clustering plots and PCAs were calculated within SeqMonk. MA plots were generated in GraphPad Prism (v9.2.0) comparing mean and difference for each gene between 2 conditions. Probes with less than 2 reads post-normalisation in the control condition were filtered as change between datasets cannot be accurately quantified in this case.

Gene Ontology term enrichment analysis

GO analysis of individual clusters performed using GOrilla (http://cbl-gorilla.cs.technion.ac.il/) [101]. Quoted p-values for GO analysis are FDR-corrected according to the Benjamini and Hochberg method (q-values from the GOrilla output). For brevity, only the order of magnitude rather than the full q-value is given [102]. Full GO analyses are provided in S7 File.

Genome resequencing mapping and analysis

After adapter and quality trimming using Trim Galore (v0.6.6), DNA-seq data were mapped to yeast genome R64-1-1 using Bowtie 2 [103] by the Babraham Institute Bioinformatics Facility. Reads were quantified in 25 kb windows spaced every 5 kb. Windows overlapping Ty elements and LTRs, mitochondrial DNA, ENA locus, and CUP1 locus were excluded, and then size factor normalisation applied [104]. For rDNA analysis, reads were quantified in 1 kb windows, 200 bp spacing, and size factor normalised.

Flow cytometry

Cell pellets were resuspended in 240 μl PBS and 9 μl 10% Triton X-100 containing 0.3 μl of 1 mg/ml Streptavidin conjugated with Alexa Fluor 647 (Life Technologies) and 0.6 μl of 1 mg/ml WGA conjugated with CF405S (Biotium). Cells were stained for 10 minutes at room temperature on a rotating mixer while covered with aluminium foil, washed once with 300 μl PBS containing 0.01% Triton X-100, resuspended in 30 μl PBS, and immediately subject to flow cytometry analysis. Flow cytometry analysis was conducted using an Amnis ImageStream X Mk II with the following laser power settings: 405 = 25 mW; 488 = 180 mW; 561 = 185 mW; 642 = 5 mW; SSC = 0.3 mW.

Cell populations were gated for single cells based on area and aspect ratio (>0.8) values, and in-focus cells were gated based on a gradient RMS value (>50). Further gating of streptavidin-positive (AF647) cells was also applied, all in a hierarchical manner and 1,000 events acquired. For budding cell analysis, 10,000 events were acquired, and based on focused images and area and aspect ratio, cells were gated into 2 groups: Single cells were gated and counted as G1 phase cells, and Budding cells (doublets or aggregates of 3 cells) were gated and counted as G2/S phase cells. Before data analysis, compensation was applied according to single-colour controls and an automatically calculated compensation matrix. Total fluorescence intensity values of different parameters were extracted using the Intensity feature of the IDEAS software, with Adaptive Erode modified mask coverage. In the analysis, only positive values of fluorescence were included (i.e., where cells were truly positive for the marker) and median values of populations were determined with Graphpad Prism (v9.2.0).

Statistical analysis

All statistical analysis other than that performed using the R DESeq2 package was performed in GraphPad Prism (v9.2.0).

Supporting information

S1 Fig. Supplement to ERCs do not cause genome-wide gene expression dysregulation.

(A) Southern blot analysis of ERC abundance in log phase and 48-hour-aged wild-type and fob1Δ MEP cells. Quantification shows ratio between sum of ERC bands and chromosome XII band for 3 biological replicates, p-value calculated by 1-way ANOVA. Images show 2 sections of the same blot membrane with no differential image processing applied. (B) Southern blot analysis of ERC abundance at log phase and indicated aged time points for wild type, rad52Δ, spt3Δ, and sac3Δ mutant MEP cells, along with a wild type in which the TRP1 gene has been restored. (C) Scatter plot of log2 mRNA abundance comparing log phase to 48-hour-aged wild type. Sets of genes called as significantly differentially expressed by DEseq2 (BH-corrected FDR < 0.05, log2-fold change threshold ±0.5) are highlighted in colour. GO terms are provided for each category, significance indicated by FDR-corrected q values, full GO term enrichment analysis in S7 File. (C) PCA summary for log phase poly(A)+ RNA-seq libraries from wild type and rad52Δ, spt3Δ, and sac3Δ mutants. (E) Hierarchical clustering analysis of the 2,606 genes significantly differentially expressed at log phase between at least 1 mutant and the wild type by DEseq2 (BH-corrected FDR < 0.01, log2-fold change threshold ±0.5). Individual biological replicates are shown; note that scale is different to other hierarchical clustering analyses presented as differences between log phase samples are smaller than age-linked changes. The numerical data underlying this Figure can be found in S8 File. BH, Benjamini–Hochberg; ERC, extrachromosomal ribosomal DNA circle; FDR, false discovery rate; GO, gene ontology; MEP, mother enrichment program; PCA, principal component analysis.

(TIF)

S2 Fig. Supplement to expression change of individual genes is not associated with ERC accumulation.

(A) Schematic of known RNA polymerase II transcripts in the intergenic spacer region of the rDNA, and quantification of noncoding transcripts orientated sense and antisense to the RNA polymerase I–transcribed 35S genes. Individual biological replicates are shown as points (3 for wild type, spt3Δ, and sac3Δ and 2 for rad52Δ), and bars show mean values for a given age and genotype. (B) Distribution of log2 mean normalised mRNA abundance for all genes in wild-type cells, including probes to rDNA intergenic spacer regions. Red arrows highlight the probe that detects the IGS1-F noncoding RNA as defined in panel A. (C) Coefficients representing the contribution of each individual DESeq2 linear model factor to mean log2 normalised mRNA abundance of cluster 2 genes (from Fig 2B) across all datasets. DESeq2 was used to model expression as dependent on 4 categorical independent variables (with an additional intercept factor): Genotype (wild type, spt3Δ, rad52Δ, sac3Δ), TRP1 auxotrophy (present, not present), Age (log phase, 24 hours, 48 hours), ERC accumulation (low, high). Coefficient values can be interpreted as the log2 normalised mRNA abundance change caused by a specific model factor being present relative to a wild-type log phase TRP1 auxotroph with low ERC levels. Solid horizontal lines within violins indicate median values, while lower and upper quartiles are indicated by dotted horizontal lines. Full output of the model is provided in S1 File. (D) As for C showing values for the 40 SIR-complex regulated genes (from Ellahi and colleagues) across all datasets. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; rDNA, ribosomal DNA.

(TIF)

S3 Fig. Supplement to mutants lacking ERCs still display signatures of the SEP.

(A) Comparison between manual bud scar counts and median WGA intensities for wild type, spt3Δ, and rad52Δ at 24- and 48-hour time points. n = 15 cells for bud scars; n = 4 medians of biological replicate populations for WGA; error bars ±1 SD. (B) Analysis of Rpl13a-mCherry to show ribosomal protein abundance. Samples and analysis as in Fig 3A. (C) Plots of Tom70-GFP, Rpl13a-mCherry, WGA, and cell size for wild-type and sac3Δ cells at indicated ages, obtained as in Fig 3A. (D) Colony size assays measuring fitness of wild type and spt3Δ cells aged in glucose. Log phase cells and cells aged 48 hours then purified live in media were placed on YPD plates by micromanipulation. Colony diameters were measured on the micromanipulator screen after 24 hours. Only cells that formed visible colonies after a further 3 days were included in the analysis. Log phase cells were taken directly from culture and colony growth measured under the same conditions. p-Values calculated by Kruskal–Wallis test, n = 18 for log wild type, 25 for log spt3Δ, 40 for aged wild type, 22 for aged spt3Δ. (E) Distribution of signal areas from flow cytometry images of Rpa190-GFP in populations of log phase cells or mother cells aged for 24 and 48 hours. A total of 1,000 cells were imaged per population after gating for circularity (all) and biotin (aged cells only, based on streptavidin-Alexa647); images were post-filtered for focus of Rpa190-GFP. (F) Distribution of signal intensities from flow cytometry images of Vph1-mCherry in populations of log phase cells or mother cells aged for 24 and 48 hours. A total of 1,000 cells were imaged per population after gating for circularity (all) and biotin (aged cells only, based on streptavidin-Alexa647); images were post-filtered for focus of Vph1-GFP. (G) Example images of unseparated clusters of cells (brightfield) originating from single aged mother cells (streptavidin stained, red). The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; SEP, senescence entry point; WGA, wheat germ agglutinin.

(TIF)

S4 Fig. Supplement to a gene expression signature for the SEP.

(A) Hierarchical clustering of log2 mRNA abundance for 290 genes called by DESeq2 Linear Model 2 as significantly different between datasets based on age. DESeq2 modelling as described for 4B, clustering procedure as for 2B. Individual biological replicates shown (3 for wild type, spt3Δ, and sac3Δ and 2 for rad52Δ). (B) Coefficients representing the contribution of each individual parameter to the differences in mRNA abundance of the set of genes significantly differentially expressed with Tom70-GFP levels across all datasets calculated using DEseq2 linear model 2 as described for 4B. (C) Log2 change of mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). Individual biological replicates are shown; boxes show median and interquartile range; whiskers show upper and lower deciles. (D) Medians of mRNA abundance change datasets (Fig 4C) for ChrXIIr and other chromosomes. Wild type and TRP1 datasets are pooled to give n = 6 per condition, p-values calculated by 1-way ANOVA with post hoc Tukey test. Red p-values indicate significance at p < 0.05. (E) Distribution of signal intensities from flow cytometry images of Tom70-GFP and WGA-Alexa405 in populations of haploid MATα log phase cells or mother cells aged for 24 and 48 hours in YPD. A total of 1,000 cells are imaged per population after gating for circularity (all) and biotin (aged cells only, based on streptavidin-Alexa647). Images are post-filtered for focus of Tom70-GFP, leaving approximately 600 cells per population. (F) Log2 change of mRNA abundance for haploid MATα MEP cells from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). (G) As Fig 4B excluding genes on ChrXIIr. The numerical data underlying this Figure can be found in S8 File. MEP, mother enrichment program; SEP, senescence entry point.

(TIF)

S5 Fig. Connecting SEP-associated gene expression change with stress and growth.

(A) Correlations between coefficients for SEP and Age, representing the contribution of these variables to gene expression change during ageing calculated by Linear Model 3, and gene expression change during a 20-minute heat shock (GSE18). Only genes participating in the ESR are included [13]. R2 values calculated by linear regression. (B) Correlation between coefficients for the SEP, representing the contribution of this variable to gene expression change during ageing calculated by Linear Model 3, and gene expression difference between specific growth rates μ = 0.1 and μ = 0.33 [66]. Only genes participating in the ESR are included [13]. R2 value calculated by linear regression; n is number of genes analysed as not all ESR genes were measured by Regenberg and colleagues. (C) Summary of correlations between coefficients for SEP and Age, representing the contribution of these variables to gene expression change during ageing calculated by Linear Model 3, and gene expression change during different stresses (GSE18). R2 values were calculated for the comparison of each individual stress dataset reported by Gasch and colleagues and the SEP/Age coefficients. R2 values were then binned into 8 different stress types, and p-values representing the differences between correlations to the SEP and Age coefficients calculated by 1-way ANOVA. (D) Correlation between gene expression change in ageing (wild type log phase to 48 hours) and in heat shock (GSE18) for the set of 187 genes significantly associated with the SEP by Linear Model 2. R2 value calculated by linear regression; n is number of genes analysed as not all the 187 SEP genes were measured by Gasch and colleagues. (E) Correlation between gene expression change in ageing (wild-type log phase to 48 hours) and between specific growth rates μ = 0.1 and μ = 0.33 [66] for the set of 187 genes significantly associated with the SEP by Linear Model 2. R2 value calculated by linear regression; n is number of genes analysed as not all the 187 SEP genes were measured by Regenberg and colleagues. The numerical data underlying this Figure can be found in S8 File. ESR, environmental stress response; SEP, senescence entry point.

(TIF)

S6 Fig. Aneuploidies emerge during ageing.

Genome resequencing data and RNA-seq data as in Figs 5C and 4C, respectively, showing mild accumulations of Chromosomes I and VI during ageing. The numerical data underlying this Figure can be found in S8 File.

(TIF)

S7 Fig. Ageing of hst3Δ hst4Δ is equivalent to rad52Δ.

(A) Cell cycle stage plots comparing the percentage of budded and unbudded cells. Imaging flow cytometry was performed with gating for streptavidin (aged samples only), then budded and unbudded cells called based on circularity and validated by examining representative images. (B) Imaging flow cytometry analysis of Tom70-GFP intensity, which increases hugely in G1 cells after the SEP [5], WGA, which reports on replicative age, and cell size in wild type and hst3Δ hst4Δ. Cells were gated for streptavidin staining (aged samples only), which filters out young cells, then for circularity, which selects towards G1 cells and removes clumps. Graph shows medians of biological replicate populations; p-values calculated from 2-way ANOVA with post hoc Tukey test using genotype and age as independent variables, n = 2. Red p-values indicate significance at p < 0.05. (C) Southern blot analysis of ERC abundance in log phase and 24-hour-aged wild-type and hst3Δ hst4Δ MEP cells; quantification shows ration of ERC bands to chromosomal rDNA. Individual lanes were spliced from the same blot image; no differential image processing was applied. (D) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from wild type and indicated mutants. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. Different matched wild-type control data are presented for each mutant; rad52Δ data are provided as a comparison for hst3Δ hst4Δ. Data for each genotype and age calculated as the log2 mean normalised read counts per gene of 2 biological replicates for mutants, 3 biological replicates for wild type. (E) Hierarchical clustering of log2 mRNA abundance for 187 genes called by a DESeq2 Linear Model 2 as significantly different between datasets based on the SEP, as in Fig 4A, for wild type, rad52Δ, and hst3Δ hst4Δ at log and 24 hours, 2 biological replicates per time point for mutants, 3 biological replicates for wild type. (F) Log2 change of mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). Data are the mean of 2 biological replicates. (G) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from wild type and mus81Δ. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. Matched wild-type control data are presented, data for each genotype and age calculated as the log2 mean normalised read counts per gene of 2 biological replicates. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; MEP, mother enrichment program; SEP, senescence entry point; WGA, wheat germ agglutinin.

(TIF)

S8 Fig. Linear model outcomes are minimally influenced by exclusion of rad52Δ dataset.

(A) Fraction of genes significantly differentially expressed based on SEP variable discovered by Linear Models 2 and 3 fitted using either the full dataset of wild type, spt3Δ, sac3Δ, and rad52Δ, or a reduced dataset of just wild type, spt3Δ, and sac3Δ. Values are observed number of genes per chromosome divided by the expected number of genes (calculated from the total number of significantly differentially expressed genes × genes on chromosome / genes in genome). Chromosome XII values are split between XII left–the region from the left telomere to the rDNA, and XIIr–from the rDNA to the right telomere (ChrXIIr). Full output of the models is provided in S4 File and S5 File. (B) Assignment of gene expression change in wild-type ageing log to 48 hours to SEP and Age contributions calculated by Linear Model 3 fitted without rad52Δ dataset, displayed as MA plots. Analysis as in Fig 4F; left panel shows wild-type ageing data for comparison and is identical to the left-hand plot in Fig 4F. The numerical data underlying this Figure can be found in S8 File.

(TIF)

S9 Fig. Supplement to increased copy number of genes telomere proximal to the rDNA on ChrXII is not responsible for the SEP.

(A) Pulsed field gel electrophoresis analysis showing successful translocation of ChrXIIr onto chromosome V. (B) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from a:a diploid wild-type and Chr XII <>V translocation strain. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. (C) Hierarchical clustering of log2 mRNA abundance for 187 genes called by a DESeq2 Linear Model 2 as significantly different between datasets based on the SEP, as in Fig 4A, excluding genes on ChrXIIr, for a: a diploid wild-type and Chr XII <>V translocation strain. The numerical data underlying this Figure can be found in S8 File. rDNA, ribosomal DNA; SEP, senescence entry point.

(TIF)

S10 Fig. Model for the formation mechanism of ChrXIIr.

(A) Replication fork dynamics leading to incomplete replication at anaphase. (i) Potential replication fork stalling elements in the rDNA include the RFB, DNA damage, and regions highly expressed by RNA polymerase I, II, and III. (ii) First replication fork stalls at the RFB or on collision with RNA polymerase I. (iii) Converging replication fork stalls due to DNA damage, collision with transcription units, topological strain, etc. (iv) Centromeres are pulled apart on the mitotic spindle, but segregation cannot be completed. (v) Cleavage of replication fork structures by structure-specific endonucleases allows segregation to complete but forms ChrXIIr. (B) ChrXIIr formation in the context of heterozygous markers. Incomplete replication leads to one chromosome forming a bridging chromosome, resolution of which either leaves both chromosome fragments in one nucleus (left), in which case the break can be repaired, or separates the fragments (right) in which case ChrXIIr formation in the mother is accompanied by loss of heterozygosity in the daughter. Further recombination events between ChrXIIr and full-length chromosome XII in the mother can lead to loss of heterozygosity also in the mother. rDNA, ribosomal DNA; RFB, replication fork barrier.

(TIF)

S1 Table. Strains used in this work.

All strains are in the MEP background; most are diploid as indicated. Wild-type alleles are indicated as +; fluorophore-tagged constructs are heterozygous to avoid growth defects.

(DOCX)

S2 Table. Oligonucleotides used in this work.

(DOCX)

S3 Table. Plasmids used in this work.

(DOCX)

S1 File. Details and output data for Linear Model 1.

Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

(XLSX)

S2 File. Details and output data for Linear Model 2.

Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

(XLSX)

S3 File. Details and output data for Linear Model 3.

Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

(XLSX)

S4 File. Genome resequencing data for individual chromosomes.

Change in age for individual chromosomes in each mutant, data processed as in Fig 5C. Scales have been kept the same as in Fig 5C to allow easy comparison.

(PDF)

S5 File. Details and output data for Linear Model 2 fitted without rad52Δ.

Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

(XLSX)

S6 File. Details and output data for Linear Model 3 fitted without rad52Δ.

Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

(XLSX)

S7 File. GO analysis for differentially expressed gene sets.

(XLSX)

S8 File. Numerical data underlying Figures.

(ZIP)

S1 Raw Images. Full unmodified gel images underlying figure panels.

(PDF)

Acknowledgments

We would like to thank Rachael Walker and Attila Bebes of the Babraham Institute Flow Facility for their assistance with imaging flow cytometry; Paula Kokko-Gonzales and Nicole Forrester of the Babraham Institute Next Generation Sequencing facility for sequencing samples and QC assistance; and Felix Krueger, Laura Biggins, and Anne Segonds-Pichon of the Babraham Institute Bioinformatics Facility for help with sample processing and statistical analysis. We thank Michelle King for Southern blot analysis; Patrick Lindstrom and Dan Gottschling for the MEP system; Gilles Charvin and Théo Aspert for helpful discussions; Luca Love and Prasanna Channathodiyil for RNA-seq data; and Nianshu Zhang and Nazif Alic for helpful suggestions regarding DESeq2 linear modelling.

Abbreviations

BH

Benjamini–Hochberg

ERC

extrachromosomal ribosomal DNA circle

ESR

environmental stress response

FDR

false discovery rate

MEP

mother enrichment program

PCA

principal component analysis

rDNA

ribosomal DNA

RFB

replication fork barrier

SEP

senescence entry point

WGA

wheat germ agglutinin

Data Availability

All RNA-seq data has been deposited at GEO under accession number GSE207429. All other relevant data are within the paper and its Supporting information files. Detailed and updated protocols are available at https://www.babraham.ac.uk/our-research/epigenetics/jon-houseley/protocols.

Funding Statement

JH and AZ were funded by the Wellcome Trust [110216], AZ and DH by BBSRC DTP PhD awards [1645489, 1947502], JH, AW and HHM by the BBSRC [BI Epigenetics ISP: BBS/E/B/000C0423], BP by Ecole Normale Superieure Paris-Saclay, Universite Paris-Saclay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Janssens GE, Veenhoff LM. Evidence for the hallmarks of human aging in replicatively aging yeast. Microb Cell. 2016;3(7):263–274. doi: 10.15698/mic2016.07.510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kaeberlein M. Lessons on longevity from budding yeast. Nature. 2010;464(7288):513–519. doi: 10.1038/nature08981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.He C, Zhou C, Kennedy BK. The yeast replicative aging model. Biochim Biophys Acta Mol Basis Dis. 2018;1864(9 Pt A):2690–2696. doi: 10.1016/j.bbadis.2018.02.023 [DOI] [PubMed] [Google Scholar]
  • 4.Mortimer RK, Johnston JR. Life span of individual yeast cells. Nature. 1959;183(4677):1751–1752. doi: 10.1038/1831751a0 [DOI] [PubMed] [Google Scholar]
  • 5.Fehrmann S, Paoletti C, Goulev Y, Ungureanu A, Aguilaniu H, Charvin G. Aging yeast cells undergo a sharp entry into senescence unrelated to the loss of mitochondrial membrane potential. Cell Rep. 2013;5(6):1589–1599. doi: 10.1016/j.celrep.2013.11.013 [DOI] [PubMed] [Google Scholar]
  • 6.Sarnoski EA, Song R, Ertekin E, Koonce N, Acar M. Fundamental Characteristics of Single-Cell Aging in Diploid Yeast. iScience. 2018;7:96–109. doi: 10.1016/j.isci.2018.08.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Janssens GE, Veenhoff LM. The Natural Variation in Lifespans of Single Yeast Cells Is Related to Variation in Cell Size, Ribosomal Protein, and Division Time. PLoS ONE. 2016;11(12):e0167394. doi: 10.1371/journal.pone.0167394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hu Z, Chen K, Xia Z, Chavez M, Pal S, Seol JH, et al. Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging. Genes Dev. 2014;28(4):396–408. doi: 10.1101/gad.233221.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Feser J, Truong D, Das C, Carson JJ, Kieft J, Harkness T, et al. Elevated histone expression promotes life span extension. Mol Cell. 2010;39(5):724–735. doi: 10.1016/j.molcel.2010.08.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lesur I, Campbell JL. The transcriptome of prematurely aging yeast cells is similar to that of telomerase-deficient cells. Mol Biol Cell. 2004;15(3):1297–1312. doi: 10.1091/mbc.e03-10-0742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yiu G, McCord A, Wise A, Jindal R, Hardee J, Kuo A, et al. Pathways change in expression during replicative aging in Saccharomyces cerevisiae. J Gerontol A Biol Sci Med Sci. 2008;63(1):21–34. doi: 10.1093/gerona/63.1.21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hendrickson DG, Soifer I, Wranik BJ, Kim G, Robles M, Gibney PA, et al. A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast. elife. 2018:7. doi: 10.7554/eLife.39911 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, Storz G, et al. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell. 2000;11(12):4241–4257. doi: 10.1091/mbc.11.12.4241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Janssens GE, Meinema AC, Gonzalez J, Wolters JC, Schmidt A, Guryev V, et al. Protein biogenesis machinery is a driver of replicative aging in yeast. elife. 2015;4:e08527. doi: 10.7554/eLife.08527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cruz C, Della Rosa M, Krueger C, Gao Q,, et al. Tri-methylation of histone H3 lysine 4 facilitates gene expression in ageing cells. elife. 2018;7:e34081. doi: 10.7554/eLife.34081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pal S, Postnikoff SD, Chavez M, Tyler JK. Impaired cohesion and homologous recombination during replicative aging in budding yeast. Sci Adv. 2018;4(2):eaaq0236. doi: 10.1126/sciadv.aaq0236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Moreno DF, Jenkins K, Morlot S, Charvin G, Csikasz-Nagy A, Aldea M. Proteostasis collapse, a hallmark of aging, hinders the chaperone-Start network and arrests cells in G1. elife. 2019;8. doi: 10.7554/eLife.48240 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Leupold S, Hubmann G, Litsios A, Meinema AC, Takhaveev V, Papagiannakis A, et al. Saccharomyces cerevisiae goes through distinct metabolic phases during its replicative lifespan. elife. 2019:8. doi: 10.7554/eLife.41046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Neurohr GE, Terry RL, Sandikci A, Zou K, Li H, Amon A. Deregulation of the G1/S-phase transition is the proximal cause of mortality in old yeast mother cells. Genes Dev. 2018;32(15–16):1075–1084. doi: 10.1101/gad.312140.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Morlot S, Song J, Leger-Silvestre I, Matifas A, Gadal O, Charvin G. Excessive rDNA Transcription Drives the Disruption in Nuclear Homeostasis during Entry into Senescence in Budding Yeast. Cell Rep. 2019;28(2):408–422 e4. doi: 10.1016/j.celrep.2019.06.032 [DOI] [PubMed] [Google Scholar]
  • 21.Neurohr GE, Terry RL, Lengefeld J, Bonney M, Brittingham GP, Moretto F, et al. Excessive Cell Growth Causes Cytoplasm Dilution And Contributes to Senescence. Cell. 2019;176(5):1083–1097 e18. doi: 10.1016/j.cell.2019.01.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Horkai D, Hadj-Moussa H, Whale AJ, Houseley J. Dietary change without caloric restriction maintains a youthful profile in ageing yeast. PLoS Biol. 2023; 21(8):e3002245. doi: 10.1371/journal.pbio.3002245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Li Y, Jiang Y, Paxman J, O’Laughlin R, Klepin S, Zhu Y, et al. A programmable fate decision landscape underlies single-cell aging in yeast. Science. 2020;369(6501):325–329. doi: 10.1126/science.aax9552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sinclair DA, Guarente L. Extrachromosomal rDNA circles—a cause of aging in yeast. Cell. 1997;91(7):1033–1042. doi: 10.1016/s0092-8674(00)80493-6 [DOI] [PubMed] [Google Scholar]
  • 25.Park PU, Defossez PA, Guarente L. Effects of mutations in DNA repair genes on formation of ribosomal DNA circles and life span in Saccharomyces cerevisiae. Mol Cell Biol. 1999;19(5):3848–3856. doi: 10.1128/MCB.19.5.3848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Defossez PA, Prusty R, Kaeberlein M, Lin SJ, Ferrigno P, Silver PA, et al. Elimination of replication block protein Fob1 extends the life span of yeast mother cells. Mol Cell. 1999;3(4):447–455. doi: 10.1016/s1097-2765(00)80472-4 [DOI] [PubMed] [Google Scholar]
  • 27.Shcheprova Z, Baldi S, Frei SB, Gonnet G, Barral Y. A mechanism for asymmetric segregation of age during yeast budding. Nature. 2008;454(7205):728–734. doi: 10.1038/nature07212 [DOI] [PubMed] [Google Scholar]
  • 28.Denoth-Lippuner A, Krzyzanowski MK, Stober C, Barral Y. Role of SAGA in the asymmetric segregation of DNA circles during yeast ageing. elife. 2014:3. doi: 10.7554/eLife.03790 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sinclair DA, Mills K, Guarente L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science. 1997;277(5330):1313–1316. doi: 10.1126/science.277.5330.1313 [DOI] [PubMed] [Google Scholar]
  • 30.Mansisidor A, Molinar T Jr, Srivastava P, Dartis DD, Pino Delgado A, Blitzblau HG, et al. Genomic Copy-Number Loss Is Rescued by Self-Limiting Production of DNA Circles. Mol Cell. 2018;72(3):583–593 e4. doi: 10.1016/j.molcel.2018.08.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kobayashi T, Horiuchi T. A yeast gene product, Fob1 protein, required for both replication fork blocking and recombinational hotspot activities. Genes Cells. 1996;1(5):465–474. doi: 10.1046/j.1365-2443.1996.d01-256.x [DOI] [PubMed] [Google Scholar]
  • 32.Kobayashi T, Heck DJ, Nomura M, Horiuchi T. Expansion and contraction of ribosomal DNA repeats in Saccharomyces cerevisiae: requirement of replication fork blocking (Fob1) protein and the role of RNA polymerase I. Genes Dev. 1998;12(24):3821–3830. doi: 10.1101/gad.12.24.3821 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13(19):2570–2580. doi: 10.1101/gad.13.19.2570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289(5487):2126–2128. doi: 10.1126/science.289.5487.2126 [DOI] [PubMed] [Google Scholar]
  • 35.Jack CV, Cruz C, Hull RM, Keller MA, Ralser M, Houseley J. Regulation of ribosomal DNA amplification by the TOR pathway. Proc Natl Acad Sci U S A. 2015;112(31):9674–9679. doi: 10.1073/pnas.1505015112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ha CW, Huh WK. Rapamycin increases rDNA stability by enhancing association of Sir2 with rDNA in Saccharomyces cerevisiae. Nucleic Acids Res. 2011;39(4):1336–1350. doi: 10.1093/nar/gkq895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Salvi JS, Chan JN, Pettigrew C, Liu TT, Wu JD, Mekhail K. Enforcement of a lifespan-sustaining distribution of Sir2 between telomeres, mating-type loci, and rDNA repeats by Rif1. Aging Cell. 2013;12(1):67–75. doi: 10.1111/acel.12020 [DOI] [PubMed] [Google Scholar]
  • 38.Lu KL, Nelson JO, Watase GJ, Warsinger-Pepe N, Yamashita YM. Transgenerational dynamics of rDNA copy number in Drosophila male germline stem cells. elife. 2018:7. doi: 10.7554/eLife.32421 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Watada E, Li S, Hori Y, Fujiki K, Shirahige K, Inada T, et al. Age-Dependent Ribosomal DNA Variations in Mice. Mol Cell Biol. 2020;40(22). doi: 10.1128/MCB.00368-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hallgren J, Pietrzak M, Rempala G, Nelson PT, Hetman M. Neurodegeneration-associated instability of ribosomal DNA. Biochim Biophys Acta. 2014;1842(6):860–868. doi: 10.1016/j.bbadis.2013.12.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Stults DM, Killen MW, Pierce HH, Pierce AJ. Genomic architecture and inheritance of human ribosomal RNA gene clusters. Genome Res. 2008;18(1):13–18. doi: 10.1101/gr.6858507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Xu B, Li H, Perry JM, Singh VP, Unruh J, Yu Z, et al. Ribosomal DNA copy number loss and sequence variation in cancer. PLoS Genet. 2017;13(6):e1006771. doi: 10.1371/journal.pgen.1006771 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Valori V, Tus K, Laukaitis C, Harris DT, LeBeau L, Maggert KA. Human rDNA copy number is unstable in metastatic breast cancers. Epigenetics. 2020;15(1–2):85–106. doi: 10.1080/15592294.2019.1649930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wang M, Lemos B. Ribosomal DNA copy number amplification and loss in human cancers is linked to tumor genetic context, nucleolus activity, and proliferation. PLoS Genet. 2017;13(9):e1006994. doi: 10.1371/journal.pgen.1006994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Cohen S, Yacobi K, Segal D. Extrachromosomal circular DNA of tandemly repeated genomic sequences in Drosophila. Genome Res. 2003;13(6A):1133–1145. doi: 10.1101/gr.907603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Cohen S, Agmon N, Sobol O, Segal D. Extrachromosomal circles of satellite repeats and 5S ribosomal DNA in human cells. Mob DNA. 2010;1(1):11. doi: 10.1186/1759-8753-1-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.King GA, Goodman JS, Schick JG, Chetlapalli K, Jorgens DM, McDonald KL, et al. Meiotic cellular rejuvenation is coupled to nuclear remodeling in budding yeast. elife. 2019:8. doi: 10.7554/eLife.47156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ünal E, Kinde B, Amon A. Gametogenesis eliminates age-induced cellular damage and resets life span in yeast. Science. 2011;332(6037):1554–1557. doi: 10.1126/science.1204349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Meinema AC, Marzelliusardottir A, Mirkovic M, Aspert T, Lee SS, Charvin G, et al. DNA circles promote yeast ageing in part through stimulating the reorganization of nuclear pore complexes. elife. 2022:11. doi: 10.7554/eLife.71196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rempel IL, Crane MM, Thaller DJ, Mishra A, Jansen DP, Janssens G, et al. Age-dependent deterioration of nuclear pore assembly in mitotic cells decreases transport dynamics. elife. 2019:8. doi: 10.7554/eLife.48186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Lindstrom DL, Gottschling DE. The mother enrichment program: a genetic system for facile replicative life span analysis in Saccharomyces cerevisiae. Genetics. 2009;183(2):413–422. doi: 10.1534/genetics.109.106229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Lindstrom DL, Leverich CK, Henderson KA, Gottschling DE. Replicative age induces mitotic recombination in the ribosomal RNA gene cluster of Saccharomyces cerevisiae. PLoS Genet. 2011;7(3):e1002015. doi: 10.1371/journal.pgen.1002015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lim S, Liu Y, Rhie BH, Kim C, Ryu HY, Ahn SH. Sus1 maintains a normal lifespan through regulation of TREX-2 complex-mediated mRNA export. Aging. 2022;14(12):4990–5012. doi: 10.18632/aging.204146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lim S, Ahn H, Duan R, Liu Y, Ryu HY, Ahn SH. The Spt7 subunit of the SAGA complex is required for the regulation of lifespan in both dividing and nondividing yeast cells. Mech Ageing Dev. 2021;196:111480. doi: 10.1016/j.mad.2021.111480 [DOI] [PubMed] [Google Scholar]
  • 55.Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Smith JS, Boeke JD. An unusual form of transcriptional silencing in yeast ribosomal DNA. Genes Dev. 1997;11(2):241–254. doi: 10.1101/gad.11.2.241 [DOI] [PubMed] [Google Scholar]
  • 57.Bryk M, Briggs SD, Strahl BD, Curcio MJ, Allis CD, Winston F. Evidence that Set1, a factor required for methylation of histone H3, regulates rDNA silencing in S. cerevisiae by a Sir2-independent mechanism. Curr Biol. 2002;12(2):165–170. doi: 10.1016/s0960-9822(01)00652-2 [DOI] [PubMed] [Google Scholar]
  • 58.Houseley J, Kotovic K, El Hage A, Tollervey D. Trf4 targets ncRNAs from telomeric and rDNA spacer regions and functions in rDNA copy number control. EMBO J. 2007;26(24):4996–5006. doi: 10.1038/sj.emboj.7601921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Li C, Mueller JE, Bryk M. Sir2 represses endogenous polymerase II transcription units in the ribosomal DNA nontranscribed spacer. Mol Biol Cell. 2006;17(9):3848–3859. doi: 10.1091/mbc.e06-03-0205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Winston F, Durbin KJ, Fink GR. The SPT3 gene is required for normal transcription of Ty elements in S. cerevisiae. Cell. 1984;39(3 Pt 2):675–682. doi: 10.1016/0092-8674(84)90474-4 [DOI] [PubMed] [Google Scholar]
  • 61.Rattray AJ, Shafer BK, Garfinkel DJ. The Saccharomyces cerevisiae DNA recombination and repair functions of the RAD52 epistasis group inhibit Ty1 transposition. Genetics. 2000;154(2):543–556. doi: 10.1093/genetics/154.2.543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ellahi A, Thurtle DM, Rine J. The Chromatin and Transcriptional Landscape of Native Saccharomyces cerevisiae Telomeres and Subtelomeric Domains. Genetics. 2015;200(2):505–521. doi: 10.1534/genetics.115.175711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chen C, Contreras R. Identifying genes that extend life span using a high-throughput screening system. Methods Mol Biol. 2007;371:237–248. doi: 10.1007/978-1-59745-361-5_18 [DOI] [PubMed] [Google Scholar]
  • 64.Patterson MN, Maxwell PH. Combining magnetic sorting of mother cells and fluctuation tests to analyze genome instability during mitotic cell aging in Saccharomyces cerevisiae. J Vis Exp. 2014. doi: 10.3791/51850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Hughes AL, Gottschling DE. An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast. Nature. 2012;492(7428):261–265. doi: 10.1038/nature11654 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Regenberg B, Grotkjaer T, Winther O, Fausboll A, Akesson M, Bro C, et al. Growth-rate regulated genes have profound impact on interpretation of transcriptome profiling in Saccharomyces cerevisiae. Genome Biol. 2006;7(11):R107. doi: 10.1186/gb-2006-7-11-r107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Brauer MJ, Huttenhower C, Airoldi EM, Rosenstein R, Matese JC, Gresham D, et al. Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast. Mol Biol Cell. 2008;19(1):352–367. doi: 10.1091/mbc.e07-08-0779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Gilchrist C, Stelkens R. Aneuploidy in yeast: Segregation error or adaptation mechanism? Yeast. 2019;36(9):525–539. doi: 10.1002/yea.3427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Delaney JR, Chou A, Olsen B, Carr D, Murakami C, Ahmed U, et al. End-of-life cell cycle arrest contributes to stochasticity of yeast replicative aging. FEMS Yeast Res. 2013;13(3):267–276. doi: 10.1111/1567-1364.12030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hachinohe M, Hanaoka F, Masumoto H. Hst3 and Hst4 histone deacetylases regulate replicative lifespan by preventing genome instability in Saccharomyces cerevisiae. Genes Cells. 2011;16(4):467–477. doi: 10.1111/j.1365-2443.2011.01493.x [DOI] [PubMed] [Google Scholar]
  • 71.Hull RM, King M, Pizza G, Krueger F, Vergara X, Houseley J. Transcription-induced formation of extrachromosomal DNA during yeast ageing. PLoS Biol. 2019;17(12):e3000471. doi: 10.1371/journal.pbio.3000471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hose J, Escalante LE, Clowers KJ, Dutcher HA, Robinson D, Bouriakov V, et al. The genetic basis of aneuploidy tolerance in wild yeast. elife. 2020:9. doi: 10.7554/eLife.52063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Carollo PS, Barra V. Chromatin epigenetics and nuclear lamina keep the nucleus in shape: Examples from natural and accelerated aging. Biol Cell. 2023;115(1):e2200023. doi: 10.1111/boc.202200023 [DOI] [PubMed] [Google Scholar]
  • 74.Falcon AA, Aris JP. Plasmid accumulation reduces life span in Saccharomyces cerevisiae. J Biol Chem. 2003;278(43):41607–41617. doi: 10.1074/jbc.M307025200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Kruitwagen T, Chymkowitch P, Denoth-Lippuner A, Enserink J, Barral Y. Centromeres License the Mitotic Condensation of Yeast Chromosome Arms. Cell. 2018;175(3):780–795 e15. doi: 10.1016/j.cell.2018.09.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Freeman L, Aragon-Alcaide L, Strunnikov A. The condensin complex governs chromosome condensation and mitotic transmission of rDNA. J Cell Biol. 2000;149(4):811–824. doi: 10.1083/jcb.149.4.811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Ganley AR, Ide S, Saka K, Kobayashi T. The effect of replication initiation on gene amplification in the rDNA and its relationship to aging. Mol Cell. 2009;35(5):683–693. doi: 10.1016/j.molcel.2009.07.012 [DOI] [PubMed] [Google Scholar]
  • 78.Johzuka K, Horiuchi T. Replication fork block protein, Fob1, acts as an rDNA region specific recombinator in S. cerevisiae. Genes Cells. 2002;7(2):99–113. doi: 10.1046/j.1356-9597.2001.00508.x [DOI] [PubMed] [Google Scholar]
  • 79.Benguria A, Hernandez P, Krimer DB, Schvartzman JB. Sir2p suppresses recombination of replication forks stalled at the replication fork barrier of ribosomal DNA in Saccharomyces cerevisiae. Nucleic Acids Res. 2003;31(3):893–898. doi: 10.1093/nar/gkg188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Chan KL, Palmai-Pallag T, Ying S, Hickson ID. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol. 2009;11(6):753–760. doi: 10.1038/ncb1882 [DOI] [PubMed] [Google Scholar]
  • 81.Torres-Rosell J, De Piccoli G, Cordon-Preciado V, Farmer S, Jarmuz A, Machin F, et al. Anaphase onset before complete DNA replication with intact checkpoint responses. Science. 2007;315(5817):1411–1415. doi: 10.1126/science.1134025 [DOI] [PubMed] [Google Scholar]
  • 82.Ivanova T, Maier M, Missarova A, Ziegler-Birling C, Dam M, Gomar-Alba M, et al. Budding yeast complete DNA synthesis after chromosome segregation begins. Nat Commun. 2020;11(1):2267. doi: 10.1038/s41467-020-16100-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Naim V, Wilhelm T, Debatisse M, Rosselli F. ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis. Nat Cell Biol. 2013;15(8):1008–1015. doi: 10.1038/ncb2793 [DOI] [PubMed] [Google Scholar]
  • 84.Chan YW, Fugger K, West SC. Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations. Nat Cell Biol. 2018;20(1):92–103. doi: 10.1038/s41556-017-0011-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Ying S, Minocherhomji S, Chan KL, Palmai-Pallag T, Chu WK, Wass T, et al. MUS81 promotes common fragile site expression. Nat Cell Biol. 2013;15(8):1001–1007. doi: 10.1038/ncb2773 [DOI] [PubMed] [Google Scholar]
  • 86.Ait Saada A, Lambert SAE, Carr AM. Preserving replication fork integrity and competence via the homologous recombination pathway. DNA Repair (Amst). 2018;71:135–147. doi: 10.1016/j.dnarep.2018.08.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Lambert S, Mizuno K, Blaisonneau J, Martineau S, Chanet R, Freon K, et al. Homologous recombination restarts blocked replication forks at the expense of genome rearrangements by template exchange. Mol Cell. 2010;39(3):346–359. doi: 10.1016/j.molcel.2010.07.015 [DOI] [PubMed] [Google Scholar]
  • 88.Ozenberger BA, Roeder GS. A unique pathway of double-strand break repair operates in tandemly repeated genes. Mol Cell Biol. 1991;11(3):1222–1231. doi: 10.1128/mcb.11.3.1222-1231.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Horigome C, Unozawa E, Ooki T, Kobayashi T. Ribosomal RNA gene repeats associate with the nuclear pore complex for maintenance after DNA damage. PLoS Genet. 2019;15(4):e1008103. doi: 10.1371/journal.pgen.1008103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Storici F, Resnick MA. The delitto perfetto approach to in vivo site-directed mutagenesis and chromosome rearrangements with synthetic oligonucleotides in yeast. Methods Enzymol. 2006;409:329–345. doi: 10.1016/S0076-6879(05)09019-1 [DOI] [PubMed] [Google Scholar]
  • 91.Longtine MS, McKenzie A 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, et al. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast. 1998;14(10):953–961. doi: [DOI] [PubMed] [Google Scholar]
  • 92.Di Tommaso P, Chatzou M, Floden EW, Barja PP, Palumbo E, Notredame C. Nextflow enables reproducible computational workflows. Nat Biotechnol. 2017;35(4):316–319. doi: 10.1038/nbt.3820 [DOI] [PubMed] [Google Scholar]
  • 93.Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38(3):276–278. doi: 10.1038/s41587-020-0439-x [DOI] [PubMed] [Google Scholar]
  • 94.Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17(1):10–12. [Google Scholar]
  • 95.Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–915. doi: 10.1038/s41587-019-0201-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930. doi: 10.1093/bioinformatics/btt656 [DOI] [PubMed] [Google Scholar]
  • 98.R Developer Core Team. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2022. [Google Scholar]
  • 99.Wickham H, Averick M, Bryan J, Chang W, Mcgowan LDA, François R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686. [Google Scholar]
  • 100.Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods. 2015;12 (2):115–121. doi: 10.1038/nmeth.3252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48. doi: 10.1186/1471-2105-10-48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate—a Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289–300. [Google Scholar]
  • 103.Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–359. doi: 10.1038/nmeth.1923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106. doi: 10.1186/gb-2010-11-10-r106 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Roland G Roberts

26 Aug 2022

Dear Jon,

Thank you for submitting your manuscript entitled "Senescence in yeast is associated with chromosome XII cleavage rather than ribosomal DNA circle accumulation" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I'm writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Aug 30 2022 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Roli

Roland Roberts, PhD

Senior Editor

PLOS Biology

rroberts@plos.org

Decision Letter 1

Roland G Roberts

31 Oct 2022

Dear Jon,

Thank you for your patience while your manuscript "Senescence in yeast is associated with chromosome XII cleavage rather than ribosomal DNA circle accumulation" was peer-reviewed at PLOS Biology. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by four independent reviewers.

As with the other manuscript, there's some significant positivity here, but again some substantial concerns which will need to be addressed. You'll see that reviewer #1 is concerned about causality here, and requests an experiment (the other issues are textual). Reviewer #2 finds this paper frustrating, as it doesn’t deliver a new model; s/he suggests a significant number of experiments but is not optimistic that the problems can be addressed satisfactorily. Reviewer #3 raises the same main concern as for the other paper (the reliance on transcriptomics), and worries about the use of rad52∆ as a model for aging and of Tom70-GFP as a marker for SEP. Reviewer #4 thinks that the findings are exciting if true, but again shares several of reviewer #3's concerns, and has some significant experimental requests. In case it's helpful, I can reveal that the reviewers appear in the same order in the two decision letters.

As you will see in the reviewer reports, which can be found at the end of this email, although the reviewers find the work potentially interesting, they have also raised a substantial number of important concerns. Based on their specific comments and following discussion with the Academic Editor, it is clear that a substantial amount of work would be required to meet the criteria for publication in PLOS Biology. However, given our and the reviewer interest in your study, we would be open to inviting a comprehensive revision of the study that thoroughly addresses all the reviewers' comments. Given the extent of revision that would be needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript would need to be seen by the reviewers again, but please note that we would not engage them unless their main concerns have been addressed.

We appreciate that these requests represent a great deal of extra work, and we are willing to relax our standard revision time to allow you 6 months to revise your study. Please email us (plosbiology@plos.org) if you have any questions or concerns, or envision needing a (short) extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted " file type.

*Resubmission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Roli

Roland Roberts, PhD

Senior Editor

PLOS Biology

rroberts@plos.org

-----------------------------------------

REVIEWS' COMMENTS:

Reviewer #1:

Numerous studies in budding yeast have demonstrated a strong correlation between aging and the accumulation of extra-chromosomal ribosomal circles (ERCs). Indeed, high levels of ERCs are widely believed to be the proximal driver of senescence, although a causal link remains unsubstantiated. In the current manuscript, the authors use mutants that are incapable of either generating or accumulating ERCs to explore the issue of causality. They show convincingly that ERC accumulation is separable from transcriptional and microscopic hallmarks of replicative aging. Furthermore, their transcriptional analyses, combined with previously published work, led them to identify a fragment of the right arm of chrXII (chrXIIr) that can arise due to replication difficulties at the rDNA. The authors show that increased levels of chrXIIr are more tightly associated with hallmarks of aging than are high levels of ERCs. This is not only interesting in itself, but it also makes discoveries about the biology of aging in yeast more relevant to that in higher eukaryotes, which don't accumulate ERCs.

The work is done carefully, and the topic will be of broad interest to readers of PLoS Biology. My major concern with the manuscript is that it left me unclear about what the authors believe to be the causal relationship between the chrXIIr fragment and replicative senescence. They have clearly demonstrated that hallmarks of aging can occur in the absence of ERC accumulation, thereby proving that ERC accumulation is not required for aging. They have also shown a correlation between appearance of the chrXIIr fragment and aging phenotypes. However, as far as I can tell, just as they argue that correlation does not imply causation with ERCs, the same thing can be argued with the chrXIIr fragment. (The chrXIIr fragment is more tightly associated with the senescence entry program, or SEP, than are ERCs, but the SEP has not been demonstrated to be causal for age-related death.) This in no way nullifies the importance and novelty of the current work, but the authors must explain their model better.

At different points in the manuscript, the authors contradict themselves about whether chrXIIr is causal for aging. For example, in the introduction, they write:

"... we implicate a large fragment of chromosome XII (ChrXIIr) as the unanticipated driver of ageing phenotypes in yeast."

while in the discussion they write:

"... ChrXIIr and ERCs can only be mediators of specific pathology rather than primary drivers of ageing ...."

In addition to clarifying their thoughts about the role of chrXIIr in aging, the authors must perform the experiment described in point 1. Below that, I make suggestions and comments to improve this very interesting manuscript.

1. Make a MATa/MATa diploid with the XII<>V translocation strain and compare this to a WT (no translocation) MATa/MATa diploid with regard to (a) replicative lifespan; (b) accumulation of chrXIIr during aging (MEP); and (c) appearance of Tom70 foci during aging (MEP). Transcriptomic analyses of these two strains would be nice as well, but not required.

2. The authors write: "In the XIIr <> V strain, ChrXIIr gene mRNAs did not increase in abundance with age, confirming that this effect arises through rDNA induced chromosomal instability (Figure 5E)." The translocation will also affect rDNA induced chromosomal instability, because when the right portion of chrXII is attached to chrV, it is no longer subject to being cut off of the end of the chromosome due to replication problems at the rDNA.

3. The authors should include a statement explicitly stating what they believe the proximal cause of aging-related death is in strains that accumulate chrXIIr. Is it loss of heterozygosity (LOH)? Altered composition of the cell wall? Anaphase chromosome bridges due to incomplete replication at the rDNA?

4. The authors should make clear that the senescence entry program (SEP) has not been established as the ultimate cause of aging-associated death. I have the impression that the authors believe that, by showing that chrXIIr is more tightly associated with the SEP than are ERCs, they have shown that chrXIIr is the "real" cause of aging, whereas ERCs are a bit of a red herring that are associated with aging but are not causal. I think that they are correct on the latter point, but it's important to keep in mind that phenotypes like accumulation of Tom70 foci could also be associated with, but not causal to, aging-related death.

5. Early on, the authors should point out that they are working with diploids, and also add a comment about why they use diploids (e.g. it allows cells to remain viable even following a LOH event). An appropriate place to insert this information would be here: "To investigate the role of ERC accumulation during replicative ageing in S. cerevisiae, we examined aged mutant cells that fail to accumulate ERCs during ageing"

6. As I understand it, there are 187 genes (rows) in the heat map in Figure 4A. It would be helpful to mention this in the legend, since it allows the reader to associate the various numbers of genes mentioned in the text with what is shown in the figures.

7. Mention whether the following RNA is c-pro or e-pro (or neither), since these are names that some people are familiar with (I believe that it is e-pro): "In fact, the IGS1-F non-coding RNA was induced sufficiently to become the most abundant poly(A)+ RNA in aged wild-type cells (Figure S2B)."

8. Label the gray box on the right side of figure 2C being a key to the symbols in the main plot, since otherwise it looks like a figure in itself.

Reviewer #2:

The authors explore the question of whether ERCs are causal in aging in budding yeast, which is a long held model in the field. The authors use the strategy of taking three yeast mutants with different levels of ERCs combined with the mother enrichment program (MEP) to see how ERCs contribute to aging. As a read out they rely on several metrics, like bud scars (WGA) to measure number of divisions, accumulation of the mitochondrial protein Tom70-GFP, and gene expression analysis. Their results are not consistent with the model. The data seems very robust with many replicates and statistics. The figures are very nice. They report on a new chromosomal element distal to the rDNA array on chr 12 that accumulates with age. They make a designer chromosome that prevents the occurrence of this species, but SEP still occurs. Their study certainly shoots a lot of holes in the model, but the new chromosomal element doesn't seem to be causal either. Although I tend to agree with the authors, based on the weight of the evidence presented, that the current ERC model is likely incorrect, the end result is somewhat unsatisfying since a new improved model doesn't really emerge, and the chromosomal species isn't demonstrated on a pulsed field gel, which seems essential. They focus the ending model on how the chromosomal species forms rather than an aging model, which is what most of the manuscript drives toward.

Some of the main problems are 1) the pleiotropic effects the deletions will have on gene expression and cell physiology, 2) the heavy reliance on specific markers i.e. Tom70-GFP without explaining why this specific marker should be trusted in all mutant contexts, 3) the complexity of the multiple gene expression models which are difficult to understand, 4) the high demand on the reader to keep track of many correlating phenotypes and for relevant background knowledge, 5) the lack of a new model to explain aging, 5) the lack of evidence for the chromosomal species. The title implies "chromosome XII cleavage" is critical for senescence which doesn't seem appropriate since cleavage itself isn't measured, how the species is generated is only a model, and a strain that doesn't generate the species still shows senescence according to Tom70-GFP.

I have made specific suggestions below for improvement. However, the resolution of these issues may be insufficient to justify publication since some of my key problems relate to the larger issue of the story the authors are trying to tell with the data that they currently have.

Specific suggestions

1. I suggest adding a small annotation to each mutant to indicate ERC hi or ERC low so that reader does not have to keep referring back to figure S1. ERCs in the mutant strains should be quantified as in S1A. In some of the figures it might help to plot the lack of correlation between ERCs and the phenotype being described.

2. If there were other SAGA or TREX mutant have accumulate ERCs to a high level, and their gene expression profiles were similar to spt3 or sac3, this would strengthen the gene expression argument.

3. In figure 2B it makes more sense tome to put the spt3 and sac3 profiles together.

4. The authors use mutations that disrupt gene expression due to effects on RNAPII. How do we know that the Tom70 phenotype cannot be attributed to different effects in each mutant?

5. The heavy reliance on Tom70-GFP as a metric for SEP needs to be justified. In fact in Horkai et al the introduction mentions a trajectory that is not associated with Tom70 accumulation.

6. The explanation of the gene expression analysis in the last paragraph on page 5 is difficult to understand.

7. How well accepted is gene expression as a metric of aging?

8. The authors use "non-ChrXIIr genes" as a control in several experiments, but it would be important to report also on using the rest of ChrXII as a control, since using the entire genome could easily wipe out non-euploid metrics.

9. The authors refer to ChrXIIr as extrachromosomal, but I don't see evidence to support this claim. The fragment could remain connected to ChrXII.

10. The fragment needs to be visualized on a PFG.

11. As the amplification of ChrXIIr does not occur in the engineered strain (Fig 5) but the SEP still occurs based on Tom70, how can the authors conclude the region is associated with SEP as marked by Tom70-GFP??? What aspects of the expression profile persist with the engineered chromosome? This engineered chromosome is a key reagent to the story.

A few typos:

Figure 2D legend does not mention the cell clusters

Figure 6 labels, "specific" not secific

Figure 2, S2 title, expression change not charge

Reviewer #3:

In the manuscript "Senescence in yeast is associated with chromosome XII cleavage rather than ribosomal DNA circle accumulation" Zylstra et al. challenge the widely accepted view that extrachromosomal rDNA circles (ERCs) are major contributors to cellular senescence and propose instead that accumulation of a fragment of chromosome XII is strongly associated with aging. This conclusion is based on the analysis of purified populations of aged mother cells of different mutant strains that accumulate less or no ERCs. In these populations, the authors perform transcriptome analysis and correlate it with different markers of cell senescence, such as the accumulation of the outer mitochondrial protein Tom70 or cell size.

In my view, the evidence suggesting that ERCs play only a minor role in cell senescence is not conclusive and not sufficient to refute previous evidence showing a strong association between the senescence transition and ERC accumulation, in particular from recent single cell-based studies (PMID: 31291577, PMID: 30042134, PMID: 32675375). The observation that a part of chromosome XII (XIIr) accumulates in old cells is interesting but not per se novel (PMID: 24532716), which the authors acknowledge, but whether and how XIIr accumulation contributes to aging has not been clear. The authors have developed an elegant tool to investigate the functional consequence of XIIr accumulation using chromosome engineering. However, preventing accumulation of XIIr does not alter the investigated aging hallmarks, and is thus rather a consequence than a driving force of aging. This leaves the interesting question of why accumulation of this chromosomal fragment is so tightly associated with aging cells. I believe that especially the role of this recurrent chromosomal abnormality is interesting to the PLOS Biology readership, but I have a number of concerns, some of which I also outlined in detail in the review to the accompanying manuscript "Dietary change without caloric restriction maintains a youthful profile in ageing yeast" from the same group. The first point applies to both manuscripts and parts of it are a direct copy.

1) My main concern is the interpretation of the transcriptome data. The indicated age dependent decrease in ribosome biogenesis genes is reminiscent of activation of the environmental stress response (ESR), which is a hallmark of aging, slow growth or permanent cell cycle arrest (PMID: 22498653, PMID: 17105650, PMID: 30739799). A terminal cell cycle arrest is entered at the end of replicative life irrespective of why and how fast cells aged. The fraction of terminally arrested cells in each population of purified aged mother cells could thus dominate the transcriptome. rad52∆ mutant cells for example have a much shorter RLS than wild type cells (11 vs 25-30, (Delaney et al 2013)). That means that at the 24h timepoint, all rad52∆ cells are terminally arrested while the wild type cells are still all cycling, while at the 48h timepoint probably most cells have entered a terminal cell cycle arrest. If the gene expression profile in aged populations is a consequence of arrested cells, it changes the interpretation of the transcriptome data. For example: If rad52∆, spt3∆ and sac3∆ mutants all display similar age-dependent gene expression changes after 48h of aging as wild type cells, this could mean that by that point they have mostly entered a terminal cell cycle arrest and not that they all age in the same way. Such data can therefore not be used to rule out the contribution of ERCs to aging in wild type cells. The authors need to control their transcriptome data for this cell cycle arrest effect by A) determining division times and the fraction of terminally arrested cells in the aged populations and B) comparing what part of the gene expression change is driven by activation of an ESR, for example by comparing to published data sets of slow growing or arrested cells.

2) Because of the complications described above, a rad52∆ mutant (and other DNA damage repair mutants) is a particularly poor model to study aging because cells stop dividing after roughly 10 divisions and mostly arrest as budded cells (indicative of G2/M arrest potentially linked to persistant DNA damage), in contrast to wild type cells that primarily arrest in G1 after 20-30 divisions (Delaney et al 2013). Despite the problematic use of rad52∆ as aging model, several interpretations strongly depend on the rad52∆ mutant strain, which often shows stronger and opposite phenotypes compared to spt3∆ and sac3∆. For example, accumulation of Tom70-GFP is accelerated in rad52∆ but occurs more slowly in spt3∆ and sac3∆ leading the authors to conclude that ERC accumulation and senescence transition are not related, because all of the above strains have no or reduced levels of ERCs. However, if the rad52∆ data were excluded from this analysis, ERC accumulation and Tom70-GFP accumulation would correlate. Similarly, age dependent changes in gene expression (Figure 2B, 2D, 4A) are often going in opposite directions in rad52∆ than in spt3∆ and sac3∆ mutants. While these data do not necessarily support a role of ERCs in affecting gene expression or the senescence transition, I don't think they present evidence against it either. Because of the above-mentioned issues with the rad52∆ mutant, I am very skeptical about results that are solely supported by the rad52∆ results.

3) Li et al 2020 (PMID: 32675375) have shown that budding yeast cells can follow different trajectories during replicative aging and identified at least two different modes characterized by either accumulation of nucleolar markers (indicative of ERC accumulation) or accumulation of aggregated mitochondria. Cells that loose mitochondrial function tend to slow down cell divisions earlier and stop dividing earlier. These aging trajectories are influenced by genotype, in particular mutant cells that prevent ERC accumulation follow the "mitochondria" aging trajectory. Thus, while Tom70-GFP may be a good marker for SEP in some cells, this may not be the case for all aging cells. To directly measure SEP, the authors should determine cell cycle durations in populations of aged cells.

4) The observed accumulation of a fragment of Chromosome XII is interesting. In particular, the XIIr <> V chromosome engineering experiment is very elegant and demonstrates that XIIr accumulation does not cause SEP itself. It would be interesting to further investigate the role of this chromosome fragment: If it is acentromeric, as suggested by the authors, do multiple copies accumulate in old mother cells (could be analyzed in single cells using FISH)? If not, is chromosome XII fragmentation a terminal event in replicative aging? An interesting idea would be that one cause of cell death in aged cells are irreparable recombination intermediates in the rDNA. This could be the reason why a fraction of old cells (30% in wt, 70% in rad52∆) arrest as budded cells and would be compatible with the observation that swaping the telomere proximal region of Chromosome XII had no effect on aging. It would predict that the telomere proximal region of Chromosome V is not associated with aging.

Reviewer #4:

In this manuscript, Zylstra et al studied yeast aging in the presence/absence of ERCs, and found that accumulation of ChrXIIr (instead of ERCs) was the primary driver of yeast aging. As their markers, the authors use Tom70-GFP showing the onset of cell division defects at the SEP, and gene expression differences/similarities measured by RNAseq in different genetic backgrounds allowing/blocking formation or accumulation of ERCs.

This is a provocative manuscript with novel claims. If validated by further experiments/controls, this work would mean a paradigm shift in the yeast aging field and would make the yeast model of aging more relevant to aging in higher eukaryotes. Despite all these (potential) excitement, I have some major concerns about this work and its claimed take-home messages:

1. At no point, the authors measure the replicative lifespan of the constructed strains. I would recommend some single-cell microfluidic assays to measure the lifespan effects of key strains/conditions shown in this manuscript.

2. Almost all of the claims/conclusions are based on RNA-seq-measured small expression variations. It's OK to perform this bulk/high-throughput analysis first but it would be necessary to focus on key genes later one at a time at the protein level (promoter-GFP fusions perhaps). But which genes? That's one of the problematic areas of this manuscript, as the authors looked into the pairwise expression variations (the right thing to do) but did not see sufficiently high number of genes for downstream analysis. Perhaps not surprisingly, there is no specific gene(s) mentioned/claimed as the causal contributor to the shown effects. I was not very excited about their using small expression variations to reach the provocative conclusions of this work.

3. Related to #2 above: Instead of small gene expression differences that are at the correlative/bulk level or SEP as the marker, there are some well-established yeast aging markers showing the pathology/physiology of yeast during its aging. It is absolutely necessary to look at least 2 such markers in the various strains the authors constructed. Equally importantly, the authors should perform live-cell tracking of aging yeast cells (carrying those markers one at a time) under the microscope and show how age affects their potential change in ERC-producing/absent/nonaccummulating cells. The same experiment should also be performed for the haploid strain which carries ChrXIIr on Chr5.

4. Studies aiming to track rDNA copy-number or its 3D dynamics are hard to perform due to genomic integration hardships (in a precise/countable manner) associated with its multi-copy nature. However, on the initially-nonrepetitive ChrXIIr, the authors can easily integrate a strong promoter driving a fluorescent reporter to the ChrXIIr region and see in live/aging cells how its expression (as a proxy for copy number changes) changes by replicative age. LacO arrays with LacI could also be integrated to observe the translocation dynamics of this region but perhaps that would be the aim of another paper.

Decision Letter 2

Roland G Roberts

23 Jun 2023

Dear Jon,

Thank you for your patience while we considered your revised manuscript "Senescence in yeast is associated with chromosome XII fragments rather than ribosomal DNA circle accumulation" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, the Academic Editor and the original reviewers.

Based on the reviews, we are likely to accept this manuscript for publication, provided you satisfactorily address the remaining points raised by the reviewers and the following data and other policy-related requests.

IMPORTANT - Please attend to the following:

a) The team was discussing your Title; it's mostly clear, but I'm not sure that "chromosome XII fragments" quite captures it; also it was noticeable that in the Abstract you mention "amplification" but not "fragments." Looking at your Discussion, my understanding is that these are amplified fragments (large and linear) from that region of chr XII, yes? So I wonder if your title should read "...amplified linear fragments of chromosome XII..." and your Abstract should mention that they're linear fragments up to ~1.8 Mb in size?

b) Please attend to the remaining concerns raised by reviewers #2, #3 and #4. The Academic Editor confirms that minor revisions, mostly textual, should satisfy all reviewer concerns.

c) Please address my Data Policy requests below; specifically, we need you to supply the numerical values underlying Figs 1CD, 2ABCD, 3ABCD, 4ABCDEF, 5ABC, 6ABCDEFG, 7CD, S1AB, S2ABCD, S3ABCDEF, S4ABCDEFG, S5ABCDE, S6, S7ABCDEFG, S8BC, either as a supplementary data file or as a permanent DOI’d deposition. I note that you have already provided 5 supplementary data files, but the relationship between these files and the Figures is unclear; please provide all of the underlying data, clearly attributable to each Fig panel.

d) Please cite the location of the data clearly in all relevant main and supplementary Figure legends, e.g. “The data underlying this Figure can be found in S1 Data” or “The data underlying this Figure can be found in https://doi.org/10.5281/zenodo.XXXXX”

e) According to your expressed wishes, I've flagged to Production that these two papers should be scheduled for co-publication.

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Best wishes,

Roli

Roland Roberts, PhD

Senior Editor,

rroberts@plos.org,

PLOS Biology

------------------------------------------------------------------------

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figs 1CD, 2ABCD, 3ABCD, 4ABCDEF, 5ABC, 6ABCDEFG, 7CD, S1AB, S2ABCD, S3ABCDEF, S4ABCDEFG, S5ABCDE, S6, S7ABCDEFG, S8BC. NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

IMPORTANT: Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

------------------------------------------------------------------------

BLOT AND GEL REPORTING REQUIREMENTS:

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

------------------------------------------------------------------------

DATA NOT SHOWN?

- Please note that per journal policy, we do not allow the mention of "data not shown", "personal communication", "manuscript in preparation" or other references to data that is not publicly available or contained within this manuscript. Please either remove mention of these data or provide figures presenting the results and the data underlying the figure(s).

------------------------------------------------------------------------

REVIEWERS' COMMENTS:

Reviewer #1:

[Accept; no comments]

Reviewer #2:

The authors have done an admirable job addressing reviewers concerns in this major revision of the manuscript. They took the concerns of the reviewers seriously and did their best job even if all concerns cannot be addressed. The message of the manuscript is quite interesting as it attempts to overturn a long held model in the field of yeast aging regarding causality of ERCs. I am still not convinced about the broad relevance to aging biology generally but that is only a minor detraction.

Because the revision is quite extensive I think it is natural to have a few new comments.

The authors have added a figure that contains a model for how the chromosome fragment impacts NPCs to create age related dysfunction. Several reviewers suggested this was needed. The model relies heavily on a previous publication. I'm not clear on why the fragment is predicted to attach to the NPC and create problems whereas normal chromosomes do not. Please clarify in the text.

The authors did not remove the original model figure regarding how the fragment forms in the first place. As stated previously, their data does not go very far to demonstrate the mechanism of formation so I was a bit surprised to see it still included although I imagine they have devoted substantial thought regarding the mechanism of formation. It makes for a somewhat unusual format with the conclusion being two model figures explaining two separate processes at the end of the manuscript. Although I do not think its essential to modify the manuscript, I would encourage the authors to consider whether they could either 1) move the mechanism of formation model to the supplement, or 2) combine the two models into a single integrated model that includes both formation and pathology.

Reviewer #3:

The authors have made a big effort to address my concerns and have added a lot of additional data to their study, especially regarding the role of slow growth and cell cycle arrest to SEP associated gene expression. I also appreciate that the authors note in the text that the gene expression data of rad52∆ mutants are outliers and in an effort to remedy these concerns they have added data for additional mutants to the manuscripts, even though some of these mutants suffer from the same issues as rad52 (involvement in DNA damage repair).

While I appreciate the authors effort, I still have some major concerns about the authors interpretation of the results. In particular, I don't see how their data supports two key conclusions:

1) The authors refute a role of ERCs in inducing cell senescence, based on the fact that mutants that do not form ERCs can still senesce. I agree with the authors interpretation that ERCs are not necessary for the SEP associated phenotypes (ERCs are not necessary). In fact, cells with irreparable DNA damage (rad52∆) might enter a terminal cell cycle arrest that will have a very similar molecular signature as cell senescence. The fact that cells can senesce without ERCs does not mean that ERCs do not contribute to SEP in wt cells. The plasmid accumulation experiment in Meinema et al 2022 suggest that indeed extrachromosomal plasmids are sufficient. The wording should be adjusted correctly.

2) The authors imply that amplification of XIIr causes SEP, but the data show a correlation, which does not prove causality. It is also possible that the partial aneuploidy is a consequence of impaired DNA damage repair and fatal cell cycle errors that are frequently observed long after cells have started to senesce (see Crane et al 2019 and Neurohr et al 2018). This interpretation fits well with the observation that rad52∆ mutants have increased levels of XIIr accumulation. The fact that XIIr does not accumulate to more than one copy per cell (which the authors suggest but this has not been analyzed) suggests that the translocation happens in the last division and not several divisions before cells stop dividing. In order to make the claim that XIIr contributes to the SEP transition (onset of slow cell divisions, which happens several divisions before cell death), the authors would at least need to show that the XIIr accumulation happens before or at the onset of the SEP, for example by using life span imaging with cells containing TetO repeats on the distal arm of chromosome XII. To establish causality, they would also need to show that preventing the translocation prevents SEP formation. As these would require quite substantial additional experiments, I suggest the authors tone down their language in regard to this model and present it as a possibility while pointing out that this is only one of several possible other interpretations.

Minor points:

3) By visual inspection it looks like the SEP associated correlation is mostly driven by the similarity between wild type and rad52∆ and the most important mutant spt3∆ (which is not short lived, has no ERCs but enters SEP) shows a much weaker correlation. Rather than comparing very different mutants and growth conditions it would be interesting to see the comparison of only wt and spt3 mutants, which have the most similar trajectories but differ in ERC levels.

4) The XIIr <-> V swap experiment is elegant, yet cells still senesce. This could be caused by accumulation of a large rDNA containing fragment as the authors argue, but it is not clear that this translocation still occurs as it is hard/impossible to distinguish from ERC accumulation. Is the control wt strain also an a/a diploid? The reason why this is important is that DNA damage repair pathways are regulated differently in haploid (a/a will behave as a haploid) and diploid (a/alpha) cells. (NHEJ is suppressed in diploids (a/alpha).

Reviewer #4:

The authors have addressed most of my comments. Regarding my last point (#4), I disagree with them: they could have used the TEF1 promoter or the GAL1 promoter (constitutively expressed in gal80 deletion background) driving stable GFP, as strong promoters; they could have seen expression level differences on the order of 50% using these systems. Average reporter expression levels for similar-age cells across the population can be surprisingly stable across the healthy aging period (Sarnoski et al, 2018, cited already).

Overall, I believe the results from the manuscript will be of interest to the broad readership of PlosBiology and I warmly recommend its acceptance for publication.

Decision Letter 3

Roland G Roberts

12 Jul 2023

Dear Jon,

Thank you for the submission of your revised Research Article "Senescence in yeast is associated with amplified linear fragments of chromosome XII rather than ribosomal DNA circle accumulation" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Sarah Zanders, I'm pleased to say that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS: We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely,

Roli

Roland G Roberts, PhD, PhD

Senior Editor

PLOS Biology

rroberts@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Supplement to ERCs do not cause genome-wide gene expression dysregulation.

    (A) Southern blot analysis of ERC abundance in log phase and 48-hour-aged wild-type and fob1Δ MEP cells. Quantification shows ratio between sum of ERC bands and chromosome XII band for 3 biological replicates, p-value calculated by 1-way ANOVA. Images show 2 sections of the same blot membrane with no differential image processing applied. (B) Southern blot analysis of ERC abundance at log phase and indicated aged time points for wild type, rad52Δ, spt3Δ, and sac3Δ mutant MEP cells, along with a wild type in which the TRP1 gene has been restored. (C) Scatter plot of log2 mRNA abundance comparing log phase to 48-hour-aged wild type. Sets of genes called as significantly differentially expressed by DEseq2 (BH-corrected FDR < 0.05, log2-fold change threshold ±0.5) are highlighted in colour. GO terms are provided for each category, significance indicated by FDR-corrected q values, full GO term enrichment analysis in S7 File. (C) PCA summary for log phase poly(A)+ RNA-seq libraries from wild type and rad52Δ, spt3Δ, and sac3Δ mutants. (E) Hierarchical clustering analysis of the 2,606 genes significantly differentially expressed at log phase between at least 1 mutant and the wild type by DEseq2 (BH-corrected FDR < 0.01, log2-fold change threshold ±0.5). Individual biological replicates are shown; note that scale is different to other hierarchical clustering analyses presented as differences between log phase samples are smaller than age-linked changes. The numerical data underlying this Figure can be found in S8 File. BH, Benjamini–Hochberg; ERC, extrachromosomal ribosomal DNA circle; FDR, false discovery rate; GO, gene ontology; MEP, mother enrichment program; PCA, principal component analysis.

    (TIF)

    S2 Fig. Supplement to expression change of individual genes is not associated with ERC accumulation.

    (A) Schematic of known RNA polymerase II transcripts in the intergenic spacer region of the rDNA, and quantification of noncoding transcripts orientated sense and antisense to the RNA polymerase I–transcribed 35S genes. Individual biological replicates are shown as points (3 for wild type, spt3Δ, and sac3Δ and 2 for rad52Δ), and bars show mean values for a given age and genotype. (B) Distribution of log2 mean normalised mRNA abundance for all genes in wild-type cells, including probes to rDNA intergenic spacer regions. Red arrows highlight the probe that detects the IGS1-F noncoding RNA as defined in panel A. (C) Coefficients representing the contribution of each individual DESeq2 linear model factor to mean log2 normalised mRNA abundance of cluster 2 genes (from Fig 2B) across all datasets. DESeq2 was used to model expression as dependent on 4 categorical independent variables (with an additional intercept factor): Genotype (wild type, spt3Δ, rad52Δ, sac3Δ), TRP1 auxotrophy (present, not present), Age (log phase, 24 hours, 48 hours), ERC accumulation (low, high). Coefficient values can be interpreted as the log2 normalised mRNA abundance change caused by a specific model factor being present relative to a wild-type log phase TRP1 auxotroph with low ERC levels. Solid horizontal lines within violins indicate median values, while lower and upper quartiles are indicated by dotted horizontal lines. Full output of the model is provided in S1 File. (D) As for C showing values for the 40 SIR-complex regulated genes (from Ellahi and colleagues) across all datasets. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; rDNA, ribosomal DNA.

    (TIF)

    S3 Fig. Supplement to mutants lacking ERCs still display signatures of the SEP.

    (A) Comparison between manual bud scar counts and median WGA intensities for wild type, spt3Δ, and rad52Δ at 24- and 48-hour time points. n = 15 cells for bud scars; n = 4 medians of biological replicate populations for WGA; error bars ±1 SD. (B) Analysis of Rpl13a-mCherry to show ribosomal protein abundance. Samples and analysis as in Fig 3A. (C) Plots of Tom70-GFP, Rpl13a-mCherry, WGA, and cell size for wild-type and sac3Δ cells at indicated ages, obtained as in Fig 3A. (D) Colony size assays measuring fitness of wild type and spt3Δ cells aged in glucose. Log phase cells and cells aged 48 hours then purified live in media were placed on YPD plates by micromanipulation. Colony diameters were measured on the micromanipulator screen after 24 hours. Only cells that formed visible colonies after a further 3 days were included in the analysis. Log phase cells were taken directly from culture and colony growth measured under the same conditions. p-Values calculated by Kruskal–Wallis test, n = 18 for log wild type, 25 for log spt3Δ, 40 for aged wild type, 22 for aged spt3Δ. (E) Distribution of signal areas from flow cytometry images of Rpa190-GFP in populations of log phase cells or mother cells aged for 24 and 48 hours. A total of 1,000 cells were imaged per population after gating for circularity (all) and biotin (aged cells only, based on streptavidin-Alexa647); images were post-filtered for focus of Rpa190-GFP. (F) Distribution of signal intensities from flow cytometry images of Vph1-mCherry in populations of log phase cells or mother cells aged for 24 and 48 hours. A total of 1,000 cells were imaged per population after gating for circularity (all) and biotin (aged cells only, based on streptavidin-Alexa647); images were post-filtered for focus of Vph1-GFP. (G) Example images of unseparated clusters of cells (brightfield) originating from single aged mother cells (streptavidin stained, red). The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; SEP, senescence entry point; WGA, wheat germ agglutinin.

    (TIF)

    S4 Fig. Supplement to a gene expression signature for the SEP.

    (A) Hierarchical clustering of log2 mRNA abundance for 290 genes called by DESeq2 Linear Model 2 as significantly different between datasets based on age. DESeq2 modelling as described for 4B, clustering procedure as for 2B. Individual biological replicates shown (3 for wild type, spt3Δ, and sac3Δ and 2 for rad52Δ). (B) Coefficients representing the contribution of each individual parameter to the differences in mRNA abundance of the set of genes significantly differentially expressed with Tom70-GFP levels across all datasets calculated using DEseq2 linear model 2 as described for 4B. (C) Log2 change of mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). Individual biological replicates are shown; boxes show median and interquartile range; whiskers show upper and lower deciles. (D) Medians of mRNA abundance change datasets (Fig 4C) for ChrXIIr and other chromosomes. Wild type and TRP1 datasets are pooled to give n = 6 per condition, p-values calculated by 1-way ANOVA with post hoc Tukey test. Red p-values indicate significance at p < 0.05. (E) Distribution of signal intensities from flow cytometry images of Tom70-GFP and WGA-Alexa405 in populations of haploid MATα log phase cells or mother cells aged for 24 and 48 hours in YPD. A total of 1,000 cells are imaged per population after gating for circularity (all) and biotin (aged cells only, based on streptavidin-Alexa647). Images are post-filtered for focus of Tom70-GFP, leaving approximately 600 cells per population. (F) Log2 change of mRNA abundance for haploid MATα MEP cells from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). (G) As Fig 4B excluding genes on ChrXIIr. The numerical data underlying this Figure can be found in S8 File. MEP, mother enrichment program; SEP, senescence entry point.

    (TIF)

    S5 Fig. Connecting SEP-associated gene expression change with stress and growth.

    (A) Correlations between coefficients for SEP and Age, representing the contribution of these variables to gene expression change during ageing calculated by Linear Model 3, and gene expression change during a 20-minute heat shock (GSE18). Only genes participating in the ESR are included [13]. R2 values calculated by linear regression. (B) Correlation between coefficients for the SEP, representing the contribution of this variable to gene expression change during ageing calculated by Linear Model 3, and gene expression difference between specific growth rates μ = 0.1 and μ = 0.33 [66]. Only genes participating in the ESR are included [13]. R2 value calculated by linear regression; n is number of genes analysed as not all ESR genes were measured by Regenberg and colleagues. (C) Summary of correlations between coefficients for SEP and Age, representing the contribution of these variables to gene expression change during ageing calculated by Linear Model 3, and gene expression change during different stresses (GSE18). R2 values were calculated for the comparison of each individual stress dataset reported by Gasch and colleagues and the SEP/Age coefficients. R2 values were then binned into 8 different stress types, and p-values representing the differences between correlations to the SEP and Age coefficients calculated by 1-way ANOVA. (D) Correlation between gene expression change in ageing (wild type log phase to 48 hours) and in heat shock (GSE18) for the set of 187 genes significantly associated with the SEP by Linear Model 2. R2 value calculated by linear regression; n is number of genes analysed as not all the 187 SEP genes were measured by Gasch and colleagues. (E) Correlation between gene expression change in ageing (wild-type log phase to 48 hours) and between specific growth rates μ = 0.1 and μ = 0.33 [66] for the set of 187 genes significantly associated with the SEP by Linear Model 2. R2 value calculated by linear regression; n is number of genes analysed as not all the 187 SEP genes were measured by Regenberg and colleagues. The numerical data underlying this Figure can be found in S8 File. ESR, environmental stress response; SEP, senescence entry point.

    (TIF)

    S6 Fig. Aneuploidies emerge during ageing.

    Genome resequencing data and RNA-seq data as in Figs 5C and 4C, respectively, showing mild accumulations of Chromosomes I and VI during ageing. The numerical data underlying this Figure can be found in S8 File.

    (TIF)

    S7 Fig. Ageing of hst3Δ hst4Δ is equivalent to rad52Δ.

    (A) Cell cycle stage plots comparing the percentage of budded and unbudded cells. Imaging flow cytometry was performed with gating for streptavidin (aged samples only), then budded and unbudded cells called based on circularity and validated by examining representative images. (B) Imaging flow cytometry analysis of Tom70-GFP intensity, which increases hugely in G1 cells after the SEP [5], WGA, which reports on replicative age, and cell size in wild type and hst3Δ hst4Δ. Cells were gated for streptavidin staining (aged samples only), which filters out young cells, then for circularity, which selects towards G1 cells and removes clumps. Graph shows medians of biological replicate populations; p-values calculated from 2-way ANOVA with post hoc Tukey test using genotype and age as independent variables, n = 2. Red p-values indicate significance at p < 0.05. (C) Southern blot analysis of ERC abundance in log phase and 24-hour-aged wild-type and hst3Δ hst4Δ MEP cells; quantification shows ration of ERC bands to chromosomal rDNA. Individual lanes were spliced from the same blot image; no differential image processing was applied. (D) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from wild type and indicated mutants. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. Different matched wild-type control data are presented for each mutant; rad52Δ data are provided as a comparison for hst3Δ hst4Δ. Data for each genotype and age calculated as the log2 mean normalised read counts per gene of 2 biological replicates for mutants, 3 biological replicates for wild type. (E) Hierarchical clustering of log2 mRNA abundance for 187 genes called by a DESeq2 Linear Model 2 as significantly different between datasets based on the SEP, as in Fig 4A, for wild type, rad52Δ, and hst3Δ hst4Δ at log and 24 hours, 2 biological replicates per time point for mutants, 3 biological replicates for wild type. (F) Log2 change of mRNA abundance from log phase to given time points for all genes on ChrXIIr (left) or all genes on chromosomes other than XII (right). Data are the mean of 2 biological replicates. (G) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from wild type and mus81Δ. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. Matched wild-type control data are presented, data for each genotype and age calculated as the log2 mean normalised read counts per gene of 2 biological replicates. The numerical data underlying this Figure can be found in S8 File. ERC, extrachromosomal ribosomal DNA circle; MEP, mother enrichment program; SEP, senescence entry point; WGA, wheat germ agglutinin.

    (TIF)

    S8 Fig. Linear model outcomes are minimally influenced by exclusion of rad52Δ dataset.

    (A) Fraction of genes significantly differentially expressed based on SEP variable discovered by Linear Models 2 and 3 fitted using either the full dataset of wild type, spt3Δ, sac3Δ, and rad52Δ, or a reduced dataset of just wild type, spt3Δ, and sac3Δ. Values are observed number of genes per chromosome divided by the expected number of genes (calculated from the total number of significantly differentially expressed genes × genes on chromosome / genes in genome). Chromosome XII values are split between XII left–the region from the left telomere to the rDNA, and XIIr–from the rDNA to the right telomere (ChrXIIr). Full output of the models is provided in S4 File and S5 File. (B) Assignment of gene expression change in wild-type ageing log to 48 hours to SEP and Age contributions calculated by Linear Model 3 fitted without rad52Δ dataset, displayed as MA plots. Analysis as in Fig 4F; left panel shows wild-type ageing data for comparison and is identical to the left-hand plot in Fig 4F. The numerical data underlying this Figure can be found in S8 File.

    (TIF)

    S9 Fig. Supplement to increased copy number of genes telomere proximal to the rDNA on ChrXII is not responsible for the SEP.

    (A) Pulsed field gel electrophoresis analysis showing successful translocation of ChrXIIr onto chromosome V. (B) MA plots comparing log2 mRNA abundance distributions between log phase and 48-hour-aged samples from a:a diploid wild-type and Chr XII <>V translocation strain. x-Axis is log2 average normalised read count; y-axis is change in log2 normalised read count from young to old. Slope is calculated by linear regression. (C) Hierarchical clustering of log2 mRNA abundance for 187 genes called by a DESeq2 Linear Model 2 as significantly different between datasets based on the SEP, as in Fig 4A, excluding genes on ChrXIIr, for a: a diploid wild-type and Chr XII <>V translocation strain. The numerical data underlying this Figure can be found in S8 File. rDNA, ribosomal DNA; SEP, senescence entry point.

    (TIF)

    S10 Fig. Model for the formation mechanism of ChrXIIr.

    (A) Replication fork dynamics leading to incomplete replication at anaphase. (i) Potential replication fork stalling elements in the rDNA include the RFB, DNA damage, and regions highly expressed by RNA polymerase I, II, and III. (ii) First replication fork stalls at the RFB or on collision with RNA polymerase I. (iii) Converging replication fork stalls due to DNA damage, collision with transcription units, topological strain, etc. (iv) Centromeres are pulled apart on the mitotic spindle, but segregation cannot be completed. (v) Cleavage of replication fork structures by structure-specific endonucleases allows segregation to complete but forms ChrXIIr. (B) ChrXIIr formation in the context of heterozygous markers. Incomplete replication leads to one chromosome forming a bridging chromosome, resolution of which either leaves both chromosome fragments in one nucleus (left), in which case the break can be repaired, or separates the fragments (right) in which case ChrXIIr formation in the mother is accompanied by loss of heterozygosity in the daughter. Further recombination events between ChrXIIr and full-length chromosome XII in the mother can lead to loss of heterozygosity also in the mother. rDNA, ribosomal DNA; RFB, replication fork barrier.

    (TIF)

    S1 Table. Strains used in this work.

    All strains are in the MEP background; most are diploid as indicated. Wild-type alleles are indicated as +; fluorophore-tagged constructs are heterozygous to avoid growth defects.

    (DOCX)

    S2 Table. Oligonucleotides used in this work.

    (DOCX)

    S3 Table. Plasmids used in this work.

    (DOCX)

    S1 File. Details and output data for Linear Model 1.

    Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

    (XLSX)

    S2 File. Details and output data for Linear Model 2.

    Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

    (XLSX)

    S3 File. Details and output data for Linear Model 3.

    Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

    (XLSX)

    S4 File. Genome resequencing data for individual chromosomes.

    Change in age for individual chromosomes in each mutant, data processed as in Fig 5C. Scales have been kept the same as in Fig 5C to allow easy comparison.

    (PDF)

    S5 File. Details and output data for Linear Model 2 fitted without rad52Δ.

    Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

    (XLSX)

    S6 File. Details and output data for Linear Model 3 fitted without rad52Δ.

    Description of the variables used, calculated Model Coefficients and Significance tables for each comparison.

    (XLSX)

    S7 File. GO analysis for differentially expressed gene sets.

    (XLSX)

    S8 File. Numerical data underlying Figures.

    (ZIP)

    S1 Raw Images. Full unmodified gel images underlying figure panels.

    (PDF)

    Attachment

    Submitted filename: zylstra et al response to reviewers - AZ.docx

    Attachment

    Submitted filename: Zylstra et al response second revision_AZ.docx

    Data Availability Statement

    All RNA-seq data has been deposited at GEO under accession number GSE207429. All other relevant data are within the paper and its Supporting information files. Detailed and updated protocols are available at https://www.babraham.ac.uk/our-research/epigenetics/jon-houseley/protocols.


    Articles from PLOS Biology are provided here courtesy of PLOS

    RESOURCES